Regulation	O
of	O
activator	B-protein
protein-1	I-protein
and	O
NF-kappa	B-protein
B	I-protein
in	O
CD8+	B-cell_type
T	I-cell_type
cells	I-cell_type
exposed	O
to	O
peripheral	B-protein
self-antigens	I-protein
.	O

The	O
transcriptional	O
events	O
that	O
control	O
T	B-cell_type
cell	I-cell_type
tolerance	O
to	O
peripheral	B-protein
self	I-protein
Ags	I-protein
are	O
still	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
analyzed	O
the	O
regulation	O
of	O
AP-1	B-protein
-	O
and	O
NF-kappa	B-protein
B	I-protein
-mediated	O
transcription	O
during	O
in	O
vivo	O
induction	O
of	O
tolerance	O
to	O
a	O
self	B-protein
Ag	I-protein
expressed	O
exclusively	O
on	O
hepatocytes	B-cell_type
.	O

Naive	B-cell_type
CD8	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
Desire	I-cell_type
(	I-cell_type
Des	I-cell_type
)	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
isolated	O
from	O
the	O
Des	O
TCR-transgenic	O
mice	O
that	O
are	O
specific	O
for	O
the	O
H-2K	B-protein
(	I-protein
b	I-protein
)	I-protein
class	I-protein
I	I-protein
Ag	I-protein
were	O
transferred	O
into	O
Alb-K	O
(	O
b	O
)	O
-transgenic	O
mice	O
that	O
express	O
the	O
H-2K	B-protein
(	I-protein
b	I-protein
)	I-protein
Ag	I-protein
on	O
hepatocytes	B-cell_type
only	O
.	O

Tolerance	O
develops	O
in	O
these	O
mice	O
.	O

We	O
found	O
that	O
the	O
self-reactive	B-cell_type
CD8	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
Des	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
were	O
transiently	O
activated	O
,	O
then	O
became	O
unresponsive	O
and	O
were	O
further	O
deleted	O
.	O

In	O
contrast	O
to	O
CD8	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
Des	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
activated	O
in	O
vivo	O
with	O
APCs	O
,	O
which	O
express	O
high	O
AP-1	B-protein
and	O
high	O
NF-kappa	B-protein
B	I-protein
transcriptional	O
activity	O
,	O
the	O
unresponsive	O
CD8	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
Des	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
expressed	O
no	O
AP-1	B-protein
and	O
only	O
weak	O
NF-kappa	B-protein
B	I-protein
transcriptional	O
activity	O
.	O

The	O
differences	O
in	O
NF-kappa	B-protein
B	I-protein
transcriptional	O
activity	O
correlated	O
with	O
the	O
generation	O
of	O
distinct	O
NF-kappa	B-protein
B	I-protein
complexes	I-protein
.	O

Indeed	O
,	O
in	O
vivo	O
primed	B-cell_type
T	I-cell_type
cells	I-cell_type
predominantly	O
express	O
p50/p50	B-protein
and	I-protein
p65/p50	I-protein
dimers	I-protein
,	O
whereas	O
these	O
p50-containing	B-protein
complexes	I-protein
are	O
barely	O
detectable	O
in	O
tolerant	B-cell_type
T	I-cell_type
cells	I-cell_type
that	O
express	O
p65-	B-protein
and	I-protein
c-Rel-containing	I-protein
complexes	I-protein
.	O

These	O
observations	O
suggest	O
that	O
fine	O
regulation	O
of	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
formation	O
may	O
determine	O
T	B-cell_type
cell	I-cell_type
fate	O
.	O

'_9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MICFOVUG	NULL
Wiki	NULL
-	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
C5a	NULL
,	NULL
s	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
|	NULL
QUIpEL	NULL
MULTIPLEX	NULL
‘	NULL
-E	NULL
+f	NULL
o	NULL
may	NULL
Afst	NULL
m	NULL
Journal	NULL
yr	NULL
Regulatlon	NULL
of	NULL
Activator	NULL
Protein-1	NULL
and	NULL
NF-KB	NULL
in	NULL
CD8	NULL
*	NULL
T	NULL
Cells	NULL
Exposed	NULL
To	NULL
Peripheral	NULL
Immunol	NULL
O8Y	NULL
Self-Antigens	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Sylvie	NULL
Guerder	NULL
,	NULL
Mercedes	NULL
Rincon	NULL
and	NULL
Anne-Marie	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Schmitt-Verhulst	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:4399-4407	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.7.4399	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/7/4399	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
56	NULL
articles	NULL
,	NULL
24	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/7/4399.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Regulation	NULL
of	NULL
Activator	NULL
Protein-1	NULL
and	NULL
NF-KB	NULL
in	NULL
CD8*	NULL
T	NULL
Cells	NULL
Exposed	NULL
To	NULL
Peripheral	NULL
Self-Antigens	NULL
'	NULL
Sylvie	NULL
Guerder	NULL
,	NULL
``	NULL
*	NULL
Mercedes	NULL
Rincon	NULL
,	NULL
``	NULL
and	NULL
Anne-Marie	NULL
Schmitt-Verhulst*	NULL
The	NULL
transcriptional	NULL
events	NULL
that	NULL
control	NULL
T	NULL
cell	NULL
tolerance	NULL
to	NULL
peripheral	NULL
self	NULL
Ags	NULL
are	NULL
still	NULL
unknown	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
regulation	NULL
of	NULL
AP-1-	NULL
and	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transcription	NULL
during	NULL
in	NULL
vivo	NULL
induction	NULL
of	NULL
tolerance	NULL
to	NULL
a	NULL
self	NULL
Ag	NULL
expressed	NULL
exclusively	NULL
on	NULL
hepatocytes	NULL
.	NULL

Naive	NULL
CD8	NULL
*	NULL
Désiré	NULL
(	NULL
Des	NULL
)	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
the	NULL
Des	NULL
TCR-transgenic	NULL
mice	NULL
that	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
H-2K	NULL
``	NULL
class	NULL
I	NULL
Ag	NULL
were	NULL
transferred	NULL
into	NULL
Alb-K	NULL
``	NULL
-transgenic	NULL
mice	NULL
that	NULL
express	NULL
the	NULL
H-2K	NULL
``	NULL
Ag	NULL
on	NULL
hepatocytes	NULL
only	NULL
.	NULL

Tolerance	NULL
develops	NULL
in	NULL
these	NULL
mice	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
self-reactive	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
activated	NULL
,	NULL
then	NULL
became	NULL
unresponsive	NULL
and	NULL
were	NULL
further	NULL
deleted	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
activated	NULL
in	NULL
vivo	NULL
with	NULL
APCs	NULL
,	NULL
which	NULL
express	NULL
high	NULL
AP-1	NULL
and	NULL
high	NULL
NF-B	NULL
transcriptional	NULL
activity	NULL
,	NULL
the	NULL
unresponsive	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
expressed	NULL
no	NULL
AP-1	NULL
and	NULL
only	NULL
weak	NULL
NF-B	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
NF-sB	NULL
transcriptional	NULL
activity	NULL
correlated	NULL
with	NULL
the	NULL
generation	NULL
of	NULL
distinct	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
vivo	NULL
primed	NULL
T	NULL
cells	NULL
predominantly	NULL
express	NULL
p50/p50	NULL
and	NULL
p65/p50	NULL
dimers	NULL
,	NULL
whereas	NULL
these	NULL
p50-containing	NULL
complexes	NULL
are	NULL
barely	NULL
detectable	NULL
in	NULL
tolerant	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
p65-	NULL
and	NULL
c-Rel-containing	NULL
complexes	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
fine	NULL
regulation	NULL
of	NULL
NF-B	NULL
complex	NULL
formation	NULL
may	NULL
determine	NULL
T	NULL
cell	NULL
fate	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
4399-4407.	NULL
tudies	NULL
over	NULL
the	NULL
past	NULL
few	NULL
years	NULL
have	NULL
indicated	NULL
a	NULL
wide	NULL
va	NULL
riety	NULL
of	NULL
mechanisms	NULL
that	NULL
lead	NULL
to	NULL
peripheral	NULL
T	NULL
cell	NULL
toler-	NULL
ance	NULL
.	NULL

Induction	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
autoreactive	NULL
T	NULL
cells	NULL
usually	NULL
preceded	NULL
by	NULL
a	NULL
transient	NULL
phase	NULL
of	NULL
activation	NULL
,	NULL
down-modulation	NULL
of	NULL
the	NULL
TCR	NULL
or	NULL
coreceptor	NULL
,	NULL
and	NULL
immune	NULL
deviation	NULL
have	NULL
been	NULL
described	NULL
in	NULL
several	NULL
transgenic	NULL
mice	NULL
models	NULL
(	NULL
1-7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
parameters	NULL
that	NULL
determine	NULL
the	NULL
mechanisms	NULL
of	NULL
peripheral	NULL
T	NULL
cell	NULL
tolerance	NULL
are	NULL
still	NULL
fully	NULL
unknown	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
requires	NULL
two	NULL
signals	NULL
,	NULL
the	NULL
antigenic	NULL
signal	NULL
and	NULL
a	NULL
second	NULL
signal	NULL
resulting	NULL
from	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
costimulatory	NULL
molecules	NULL
B7.1	NULL
and	NULL
B7.2	NULL
,	NULL
expressed	NULL
by	NULL
activated	NULL
APCs	NULL
,	NULL
and	NULL
the	NULL
CD28	NULL
receptor	NULL
expressed	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

(	NULL
8	NULL
)	NULL
)	NULL
.	NULL

TCR	NULL
ligation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
costimulatory	NULL
signal	NULL
is	NULL
thought	NULL
to	NULL
induce	NULL
T	NULL
cell	NULL
unresponsiveness	NULL
,	NULL
a	NULL
mechanism	NULL
that	NULL
contributes	NULL
to	NULL
peripheral	NULL
T	NULL
cell	NULL
tolerance	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
signaling	NULL
cascades	NULL
triggered	NULL
by	NULL
coligation	NULL
of	NULL
the	NULL
TCR	NULL
and	NULL
CD28	NULL
receptors	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
including	NULL
AP-1	NULL
,	NULL
NF-AT	NULL
,	NULL
and	NULL
NF-KB	NULL
,	NULL
which	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
different	NULL
steps	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
may	NULL
participate	NULL
in	NULL
T	NULL
cell	NULL
survival	NULL
.	NULL

*Centre	NULL
d'Immunologie	NULL
de	NULL
Marseille-Luminy	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale/Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique/Université	NULL
de	NULL
la	NULL
Méditerranée	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
Program	NULL
of	NULL
Immu-nobiology	NULL
,	NULL
University	NULL
of	NULL
Vermont	NULL
,	NULL
Burlington	NULL
,	NULL
VT	NULL
05405	NULL
Received	NULL
for	NULL
publication	NULL
November	NULL
22	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
January	NULL
30	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
institutional	NULL
grants	NULL
(	NULL
to	NULL
S.G.	NULL
and	NULL
A.-M.S.-V.	NULL
)	NULL
from	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
and	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
grants	NULL
from	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
(	NULL
Axe	NULL
Immunologic	NULL
des	NULL
Tumeurs	NULL
)	NULL
,	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
(	NULL
Comité	NULL
des	NULL
Bouches	NULL
du	NULL
Rhone	NULL
)	NULL
and	NULL
Groupement	NULL
des	NULL
Entreprises	NULL
Frangaises	NULL
dans	NULL
la	NULL
Lutte	NULL
Contre	NULL
le	NULL
Cancer	NULL
,	NULL
and	NULL
Grant	NULL
R29A142138	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
to	NULL
M.R	NULL
.	NULL
)	NULL

.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Sylvic	NULL
Guerder	NULL
,	NULL
Centre	NULL
d	NULL
'	NULL
Immunologie	NULL
de	NULL
Marseille-Luminy	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale/Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique/Université	NULL
de	NULL
la	NULL
Méditerranée	NULL
,	NULL
Parc	NULL
Scientifique	NULL
de	NULL
Luminy	NULL
,	NULL
Case	NULL
906	NULL
,	NULL
13288	NULL
Marseille	NULL
Cedex	NULL
09	NULL
,	NULL
France	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
guerder	NULL
@	NULL
ciml.univ-mrs.fr	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
a	NULL
complex	NULL
between	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
(	NULL
cFos	NULL
,	NULL
FosB	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
)	NULL
and	NULL
Jun	NULL
(	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
)	NULL
families	NULL
of	NULL
proteins	NULL
(	NULL
10	NULL
)	NULL
.	NULL

AP-1	NULL
transcriptional	NULL
activity	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
both	NULL
fos	NULL
and	NULL
jun	NULL
gene	NULL
transcription	NULL
and	NULL
by	NULL
post-transcriptional	NULL
modifications	NULL
of	NULL
the	NULL
corresponding	NULL
protein	NULL
,	NULL
induced	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
CD28-dependent	NULL
signaling	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
and	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
cycle	NULL
(	NULL
10	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
NF-KB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
is	NULL
composed	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50/p105	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B2	NULL
(	NULL
p52/p100	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
,	NULL
which	NULL
upon	NULL
homo-	NULL
or	NULL
heterodimerization	NULL
bind	NULL
to	NULL
«	NULL
B	NULL
motifs	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

(	NULL
14	NULL
)	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
dimers	NULL
are	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
the	NULL
inhibitory	NULL
protein	NULL
of	NULL
«	NULL
B	NULL
(	NULL
IxB	NULL
)	NULL
,	NULL
``	NULL
which	NULL
,	NULL
upon	NULL
activation	NULL
,	NULL
is	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
,	NULL
thus	NULL
releasing	NULL
the	NULL
NF-KB	NULL
complexes	NULL
that	NULL
can	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
p65	NULL
and	NULL
p50	NULL
molecules	NULL
and	NULL
c-Rel	NULL
appear	NULL
to	NULL
be	NULL
the	NULL
essential	NULL
regulators	NULL
of	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
p65/p50	NULL
and	NULL
p65/c-Rel	NULL
heterodimers	NULL
act	NULL
as	NULL
positive	NULL
regulators	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
cytokine	NULL
gene	NULL
expression	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
p50	NULL
molecule	NULL
lacks	NULL
the	NULL
transactivation	NULL
domain	NULL
present	NULL
in	NULL
p65	NULL
and	NULL
c-Rel	NULL
,	NULL
and	NULL
p50/p50	NULL
homodimers	NULL
may	NULL
therefore	NULL
be	NULL
negative	NULL
regulators	NULL
of	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
14	NULL
)	NULL
.	NULL

NF-KB	NULL
also	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
protecting	NULL
cells	NULL
from	NULL
TNF-	NULL
«	NULL
@	NULL
-induced	NULL
apoptosis	NULL
(	NULL
17-21	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
protects	NULL
mature	NULL
T	NULL
cells	NULL
from	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

Indeed	NULL
,	NULL
mature	NULL
CD4	NULL
*	NULL
or	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
a	NULL
mouse	NULL
transgenic	NULL
for	NULL
a	NULL
frans-dominant	NULL
I	NULL
«	NULL
Ba	NULL
,	NULL
which	NULL
completely	NULL
blocks	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
p65/p50	NULL
and	NULL
c-Rel	NULL
complexes	NULL
,	NULL
present	NULL
an	NULL
increased	NULL
susceptibility	NULL
to	NULL
activation-induced	NULL
apoptosis	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

NF-kB	NULL
may	NULL
also	NULL
function	NULL
as	NULL
a	NULL
proapoptotic	NULL
factor	NULL
for	NULL
some	NULL
cell	NULL
lines	NULL
and	NULL
for	NULL
thymocytes	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
anergy	NULL
suggested	NULL
that	NULL
perturbed	NULL
activation	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
lead	NULL
to	NULL
T	NULL
cell	NULL
unresponsiveness	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
CD4+*	NULL
T	NULL
cells	NULL
made	NULL
anergic	NULL
by	NULL
repeated	NULL
injection	NULL
of	NULL
the	NULL
superantigen	NULL
staphylococcal	NULL
enterotoxin	NULL
A	NULL
have	NULL
reduced	NULL
AP-1	NULL
and	NULL
altered	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
as	NULL
compared	NULL
with	NULL
activated	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

However	NULL
,	NULL
how	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
IB	NULL
,	NULL
inhibitor	NULL
of	NULL
xB	NULL
;	NULL
Des	NULL
,	NULL
Désiré	NULL
;	NULL
AP-1-Luc	NULL
,	NULL
AP-l-luciferase	NULL
;	NULL
NE-	NULL
«	NULL
B-Luc	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
luciferase	NULL
;	NULL
RLU	NULL
,	NULL
relative	NULL
luminescence	NULL
units	NULL
;	NULL
HPRT	NULL
,	NULL
hypoxanthine	NULL
phosphoribosyl	NULL
transferase	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
.	NULL

0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4400	NULL
REGULATION	NULL
OF	NULL
AP-1	NULL
AND	NULL
NF-	NULL
«	NULL
B	NULL
DURING	NULL
CD8	NULL
T	NULL
CELL	NULL
TOLERANCE	NULL
these	NULL
observations	NULL
may	NULL
apply	NULL
to	NULL
T	NULL
cell	NULL
tolerance	NULL
to	NULL
a	NULL
peripheral	NULL
self	NULL
Ag	NULL
remained	NULL
to	NULL
be	NULL
evaluated	NULL
.	NULL

We	NULL
therefore	NULL
established	NULL
a	NULL
transfer	NULL
model	NULL
to	NULL
directly	NULL
analyze	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
as	NULL
tolerance	NULL
develops	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
the	NULL
Désiré	NULL
(	NULL
Des	NULL
)	NULL
TCR-transgenic	NULL
mice	NULL
that	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
H-2K	NULL
``	NULL
class	NULL
I	NULL
Ag	NULL
were	NULL
injected	NULL
into	NULL
Alb-K	NULL
``	NULL
®	NULL
mice	NULL
that	NULL
express	NULL
the	NULL
H-2K	NULL
``	NULL
transgene	NULL
exclusively	NULL
on	NULL
hepatocytes	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Tolerance	NULL
is	NULL
established	NULL
in	NULL
these	NULL
mice	NULL
.	NULL

We	NULL
found	NULL
that	NULL
self-reactive	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
activated	NULL
,	NULL
then	NULL
became	NULL
unresponsive	NULL
and	NULL
were	NULL
further	NULL
deleted	NULL
.	NULL

The	NULL
unresponsive	NULL
T	NULL
cells	NULL
expressed	NULL
no	NULL
AP-1	NULL
and	NULL
only	NULL
weak	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
.	NULL

This	NULL
contrasts	NULL
with	NULL
T	NULL
cells	NULL
primed	NULL
in	NULL
vivo	NULL
under	NULL
conditions	NULL
known	NULL
to	NULL
induce	NULL
effector	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
high	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
transcriptional	NULL
activity	NULL
detected	NULL
in	NULL
the	NULL
primed	NULL
and	NULL
unresponsive	NULL
population	NULL
correlated	NULL
with	NULL
differences	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
generated	NULL
,	NULL
suggesting	NULL
that	NULL
fine	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
gene	NULL
expression	NULL
may	NULL
determine	NULL
the	NULL
fate	NULL
of	NULL
autoreactive	NULL
T	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Mice	NULL
The	NULL
Alb-K	NULL
``	NULL
mice	NULL
are	NULL
transgenic	NULL
for	NULL
the	NULL
class	NULL
I	NULL
H-2K	NULL
``	NULL
molecule	NULL
driven	NULL
by	NULL
the	NULL
albumin	NULL
promoter	NULL
and	NULL
express	NULL
H-2K	NULL
``	NULL
on	NULL
hepatocytes	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
Des	NULL
mice	NULL
are	NULL
transgenic	NULL
for	NULL
a	NULL
TCR	NULL
specific	NULL
for	NULL
the	NULL
H-2K	NULL
``	NULL
molecule	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
AP-1-luciferase	NULL
(	NULL
AP-1-Luc	NULL
)	NULL
-	NULL
and	NULL
NF-	NULL
«	NULL
B-Luciferase	NULL
(	NULL
NF-	NULL
«	NULL
B-Luc	NULL
)	NULL
-transgenic	NULL
mice	NULL
contain	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
,	NULL
controlled	NULL
by	NULL
four	NULL
AP-1	NULL
sites	NULL
or	NULL
two	NULL
NF-KB	NULL
sites	NULL
,	NULL
respectively	NULL
(	NULL
11	NULL
,	NULL
28	NULL
)	NULL
.	NULL

All	NULL
mice	NULL
were	NULL
backcrossed	NULL
for	NULL
at	NULL
least	NULL
six	NULL
generations	NULL
on	NULL
a	NULL
B10.BR	NULL
background	NULL
.	NULL

The	NULL
CBK-transgenic	NULL
mice	NULL
express	NULL
the	NULL
H-2K	NULL
``	NULL
molecule	NULL
on	NULL
all	NULL
hematopoietic	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Adoptive	NULL
transfer	NULL
Alb-K®-transgenic	NULL
mice	NULL
or	NULL
control	NULL
B10.BR	NULL
mice	NULL
were	NULL
thymectomized	NULL
at	NULL
the	NULL
age	NULL
of	NULL
4-6	NULL
wk	NULL
,	NULL
rested	NULL
for	NULL
3-4	NULL
wk	NULL
,	NULL
and	NULL
y-irradiated	NULL
at	NULL
6	NULL
Gy	NULL
.	NULL

After	NULL
11-15	NULL
days	NULL
,	NULL
the	NULL
mice	NULL
were	NULL
injected	NULL
i.v	NULL
.	NULL

with	NULL
5-8	NULL
X	NULL
10°	NULL
T	NULL
cells	NULL
purified	NULL
from	NULL
Des-transgenic	NULL
mice	NULL
.	NULL

The	NULL
low	NULL
dose	NULL
of	NULL
irradiation	NULL
eliminates	NULL
most	NULL
circulating	NULL
lymphocytes	NULL
while	NULL
sparing	NULL
bone	NULL
marrow	NULL
precursors	NULL
.	NULL

Reconsti-tution	NULL
of	NULL
the	NULL
peripheral	NULL
pool	NULL
of	NULL
lymphocytes	NULL
by	NULL
endogenous	NULL
precursors	NULL
was	NULL
completed	NULL
by	NULL
the	NULL
time	NULL
of	NULL
adoptive	NULL
transfer	NULL
.	NULL

Because	NULL
the	NULL
mice	NULL
were	NULL
thymectomized	NULL
,	NULL
only	NULL
the	NULL
B	NULL
cell	NULL
compartment	NULL
but	NULL
not	NULL
the	NULL
T	NULL
cell	NULL
compartment	NULL
was	NULL
replenished	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
spleen	NULL
of	NULL
such	NULL
manipulated	NULL
mice	NULL
contained	NULL
,	NULL
on	NULL
average	NULL
,	NULL
3	NULL
%	NULL
CD4*	NULL
T	NULL
cells	NULL
and	NULL
3	NULL
%	NULL
CD8*	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
when	NULL
adoptively	NULL
transferred	NULL
,	NULL
2-3	NULL
%	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Abs	NULL
and	NULL
FACS	NULL
staining	NULL
FITC-labeled	NULL
anti-CD25	NULL
,	NULL
-CD44	NULL
,	NULL
-CD62L	NULL
,	NULL
and	NULL
-CD69	NULL
Ab	NULL
and	NULL
PE-labeled	NULL
anti-CD4	NULL
and	NULL
-CD8	NULL
Abs	NULL
were	NULL
purchased	NULL
from	NULL
BD	NULL
PharMingen	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
Des	NULL
anti-clonotype	NULL
and	NULL
H59.101.2	NULL
anti-CD8	NULL
Ab	NULL
were	NULL
prepared	NULL
and	NULL
biotinylated	NULL
at	NULL
the	NULL
Centre	NULL
d'Immunologie	NULL
de	NULL
Marseille-Luminy	NULL
.	NULL

For	NULL
FACS	NULL
staining	NULL
,	NULL
all	NULL
samples	NULL
were	NULL
triple	NULL
stained	NULL
for	NULL
the	NULL
clonotype	NULL
,	NULL
CD4	NULL
or	NULL
CD8	NULL
,	NULL
and	NULL
one	NULL
activation	NULL
marker	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
biotinylated	NULL
Des	NULL
Ab	NULL
,	NULL
washed	NULL
two	NULL
times	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
Strepta-vin-Tricolor	NULL
(	NULL
Caltag	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
FITC-	NULL
and	NULL
PE-conjugated	NULL
Ab	NULL
.	NULL

Cell	NULL
preparation	NULL
Lymph	NULL
node	NULL
T	NULL
cells	NULL
used	NULL
for	NULL
adoptive	NULL
transfer	NULL
were	NULL
prepared	NULL
by	NULL
depletion	NULL
of	NULL
B	NULL
cells	NULL
using	NULL
sheep	NULL
anti-mouse	NULL
IgG	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Nor-way	NULL
)	NULL
.	NULL

On	NULL
average	NULL
,	NULL
the	NULL
population	NULL
recovered	NULL
contained	NULL
<	NULL
5	NULL
%	NULL
non-T	NULL
cells	NULL
and	NULL
was	NULL
composed	NULL
of	NULL
<	NULL
5	NULL
%	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
of	NULL
which	NULL
50	NULL
%	NULL
expressed	NULL
the	NULL
Des	NULL
TCR	NULL
,	NULL
and	NULL
~80	NULL
%	NULL
CD8*	NULL
T	NULL
cells	NULL
,	NULL
of	NULL
which	NULL
>	NULL
90	NULL
%	NULL
were	NULL
Des*	NULL
.	NULL

When	NULL
indi-cated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
CFSE	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Purified	NULL
CD8	NULL
*	NULL
or	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
MACS	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
separation	NULL
using	NULL
either	NULL
biotinylated	NULL
anti-CD8	NULL
or	NULL
Des	NULL
Ab	NULL
,	NULL
dichlorotriazinylaminofluo-rescein-conjugated	NULL
streptavidin	NULL
(	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
,	NULL
and	NULL
MACS	NULL
biotin-conjugated	NULL
beads	NULL
.	NULL

Purity	NULL
of	NULL
the	NULL
recovered	NULL
population	NULL
was	NULL
<	NULL
90	NULL
%	NULL
.	NULL

To	NULL
isolate	NULL
liver-infiltrating	NULL
cells	NULL
,	NULL
mice	NULL
were	NULL
perfused	NULL
with	NULL
PBS	NULL
.	NULL

Livers	NULL
were	NULL
pressed	NULL
through	NULL
nylon	NULL
mesh	NULL
and	NULL
passed	NULL
over	NULL
a	NULL
Ficoll	NULL
cushion	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
were	NULL
prepared	NULL
by	NULL
Ab-mediated	NULL
complement	NULL
lysis	NULL
using	NULL
an	NULL
anti-Thy1.2	NULL
Ab	NULL
(	NULL
JJ	NULL
)	NULL
and	NULL
y-irradiated	NULL
at	NULL
24	NULL
Gy	NULL
.	NULL

Four	NULL
million	NULL
responder	NULL
spleen	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
2	NULL
X	NULL
10°	NULL
APCs	NULL
.	NULL

Before	NULL
stimulation	NULL
,	NULL
the	NULL
representation	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
different	NULL
spleen	NULL
populations	NULL
was	NULL
determined	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

This	NULL
value	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
all	NULL
samples	NULL
and	NULL
calculate	NULL
the	NULL
biologic	NULL
activity	NULL
of	NULL
interest	NULL
for	NULL
5	NULL
%	NULL
10°	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
.	NULL

Luciferase	NULL
assays	NULL
Cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
,	NULL
then	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
luciferase	NULL
assay	NULL
system	NULL
;	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
developed	NULL
using	NULL
the	NULL
luciferase	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

All	NULL
measurements	NULL
were	NULL
done	NULL
in	NULL
duplicate	NULL
.	NULL

The	NULL
background	NULL
measurement	NULL
was	NULL
always	NULL
below	NULL
the	NULL
activity	NULL
found	NULL
in	NULL
extracts	NULL
from	NULL
nonstimulated	NULL
cells	NULL
.	NULL

Experimental	NULL
values	NULL
expressed	NULL
as	NULL
relative	NULL
luminescence	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
were	NULL
therefore	NULL
calculated	NULL
by	NULL
subtracting	NULL
the	NULL
value	NULL
of	NULL
unstimulated	NULL
samples	NULL
from	NULL
each	NULL
sample	NULL
.	NULL

To	NULL
correct	NULL
for	NULL
the	NULL
difference	NULL
in	NULL
CD8*Des*	NULL
representation	NULL
in	NULL
the	NULL
different	NULL
samples	NULL
,	NULL
the	NULL
experimental	NULL
value	NULL
for	NULL
5	NULL
X	NULL
10°	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
was	NULL
calculated	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

Cytokine	NULL
measurements	NULL
IL-2	NULL
production	NULL
was	NULL
measured	NULL
by	NULL
bioassay	NULL
using	NULL
the	NULL
CTLL-2	NULL
cell	NULL
line	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

IFN-y	NULL
production	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
using	NULL
the	NULL
AN18	NULL
and	NULL
biotinylated	NULL
R46A2	NULL
Abs	NULL
and	NULL
alkaline	NULL
phosphatase-con-jugated	NULL
streptavidin	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
cytokine	NULL
was	NULL
expressed	NULL
as	NULL
units	NULL
compared	NULL
with	NULL
a	NULL
standard	NULL
curve	NULL
obtained	NULL
with	NULL
recom-binant	NULL
cytokines	NULL
and	NULL
corrected	NULL
for	NULL
the	NULL
representation	NULL
of	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
each	NULL
sample	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

RNA	NULL
preparation	NULL
and	NULL
RT-PCR	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
the	NULL
High	NULL
Pure	NULL
RNA	NULL
Isolation	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
in-structions	NULL
,	NULL
treated	NULL
with	NULL
DNase	NULL
I	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
and	NULL
reverse	NULL
transcribed	NULL
using	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
5	NULL
and	NULL
SuperScript	NULL
II	NULL
RT	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
amplified	NULL
using	NULL
specific	NULL
primers	NULL
and	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
normalized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
expression	NULL
of	NULL
hypoxanthine	NULL
phosphoribosyl	NULL
transferase	NULL
(	NULL
HPRT	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Luciferase	NULL
mRNA	NULL
was	NULL
quantified	NULL
using	NULL
as	NULL
forward	NULL
primer	NULL
,	NULL
5-CGCGGAATACTTCGAAATGTC-3	NULL
'	NULL
,	NULL
and	NULL
reverse	NULL
primer	NULL
,	NULL
5'-CCTTAGGTAACCCAGTAGATCC	NULL
.	NULL

Samples	NULL
were	NULL
denatured	NULL
for	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
,	NULL
and	NULL
cycling	NULL
conditions	NULL
were	NULL
94°C	NULL
for	NULL
40	NULL
s	NULL
,	NULL
58°C	NULL
for	NULL
20	NULL
s	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
40	NULL
s	NULL
for	NULL
35	NULL
cycles	NULL
.	NULL

Samples	NULL
were	NULL
quantified	NULL
by	NULL
phosphor	NULL
imager	NULL
after	NULL
hybridization	NULL
with	NULL
a	NULL
luciferase-specific	NULL
probe	NULL
(	NULL
Fujifilm	NULL
Bas-1500	NULL
;	NULL
Fuji	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
expressed	NULL
compared	NULL
with	NULL
a	NULL
standard	NULL
curve	NULL
obtained	NULL
with	NULL
a	NULL
luciferase	NULL
plasmid	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
luciferase	NULL
mRNA	NULL
per	NULL
5000	NULL
fg	NULL
HPRT	NULL
was	NULL
then	NULL
calculated	NULL
.	NULL

The	NULL
measurements	NULL
were	NULL
always	NULL
performed	NULL
in	NULL
the	NULL
exponential	NULL
phase	NULL
of	NULL
the	NULL
reaction	NULL
,	NULL
with	NULL
the	NULL
standard	NULL
curve	NULL
obtained	NULL
with	NULL
the	NULL
plasmid	NULL
template	NULL
having	NULL
an	NULL
equation	NULL
with	NULL
a	NULL
correlation	NULL
factor	NULL
of	NULL
>	NULL
0.9	NULL
.	NULL

Finally	NULL
,	NULL
some	NULL
samples	NULL
were	NULL
reanalyzed	NULL
by	NULL
real-time	NULL
quantitative	NULL
PCR	NULL
and	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

Protein	NULL
extract	NULL
,	NULL
EMSAs	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
obtained	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
CD8*	NULL
or	NULL
Des*	NULL
T	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
KCL	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.75	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.625	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
containing	NULL
protease	NULL
inhibitors	NULL
(	NULL
0.5	NULL
mM	NULL
PMSF	NULL
and	NULL
2	NULL
pg/ml	NULL
aprotenin	NULL
,	NULL
leu-peptin	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
chymostatin	NULL
,	NULL
and	NULL
antipain	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
collected	NULL
after	NULL
centrifugation	NULL
,	NULL
and	NULL
nuclei	NULL
were	NULL
lysed	NULL
in	NULL
Nuclear	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EGTA	NULL
)	NULL
containing	NULL
protease	NULL
inhibitors	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

For	NULL
EMSA	NULL
,	NULL
the	NULL
binding	NULL
reaction	NULL
was	NULL
conducted	NULL
using	NULL
2.5-3	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
and	NULL
10°	NULL
cpm	NULL
of	NULL
*P-end-labeled	NULL
double-stranded	NULL
NF-KB	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
mouse	NULL
«	NULL
B	NULL
intronic	NULL
enhancer	NULL
(	NULL
5-GATCAGAGGGGACTTTCCGAG-3	NULL
'	NULL
)	NULL
,	NULL
a	NULL
consensus	NULL
AP-1	NULL
(	NULL
5-GTCGACGTGAGCGCGC-3	NULL
'	NULL
)	NULL
,	NULL
or	NULL
consensus	NULL
OCT1-and	NULL
2-binding	NULL
oligonucleotides	NULL
(	NULL
5'-TTCTAGTGATTTGCATTCGACA-3	NULL
``	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
blocking	NULL
Ab	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Eight	NULL
to	NULL
ten	NULL
micrograms	NULL
of	NULL
the	NULL
same	NULL
extracts	NULL
were	NULL
run	NULL
on	NULL
a	NULL
10	NULL
%	NULL
poly-acrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
PolyScreen	NULL
membrane	NULL
,	NULL
and	NULL
revealed	NULL
using	NULL
ECL	NULL
Plus	NULL
(	NULL
Amersham	NULL
Life	NULL
Science	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
U.	NULL
K.	NULL
)	NULL
reagents	NULL
and	NULL
HPRT-conjugated	NULL
protein	NULL
A	NULL
or	NULL
protein	NULL
G	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
different	NULL
blots	NULL
were	NULL
quantified	NULL
by	NULL
a	NULL
luminescent	NULL
image	NULL
analyzer	NULL
(	NULL
LAS-1000	NULL
plus	NULL
;	NULL
Fuji	NULL
)	NULL
.	NULL

Abs	NULL
used	NULL
for	NULL
supershifts	NULL
or	NULL
Western	NULL
blots	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
were	NULL
the	NULL
p6S-specific	NULL
Ab	NULL
sc-109	NULL
,	NULL
the	NULL
pS5O-specific	NULL
Ab	NULL
sc-1192	NULL
,	NULL
the	NULL
c-Rel-specific	NULL
Ab	NULL
sc-70	NULL
,	NULL
the	NULL
anti-Bcel-2	NULL
Ab	NULL
sc-492	NULL
,	NULL
the	NULL
anti-Bel-x	NULL
;	NULL
,	NULL
Ab	NULL
sc-634	NULL
,	NULL
and	NULL
an	NULL
actin-specific	NULL
Ab	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Results	NULL
Deletion	NULL
of	NULL
CD8	NULL
Des	NULL
``	NULL
T	NULL
cells	NULL
following	NULL
transfer	NULL
into	NULL
Alb-K	NULL
``	NULL
-transgenic	NULL
mice	NULL
To	NULL
define	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
T	NULL
cell	NULL
tolerance	NULL
to	NULL
a	NULL
peripheral	NULL
self	NULL
Ag	NULL
,	NULL
we	NULL
developed	NULL
an	NULL
adoptive	NULL
transfer	NULL
model	NULL
that	NULL
enabled	NULL
us	NULL
to	NULL
analyze	NULL
the	NULL
transcriptional	NULL
program	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
course	NULL
of	NULL
tolerance	NULL
induction	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
donor	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
the	NULL
Des	NULL
TCR-transgenic	NULL
mice	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
H-2K	NULL
``	NULL
class	NULL
I	NULL
Ag	NULL
and	NULL
express	NULL
the	NULL
Des	NULL
clonotype	NULL
(	NULL
referred	NULL
to	NULL
thereafter	NULL
as	NULL
CD8	NULL
*	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
were	NULL
injected	NULL
into	NULL
either	NULL
Alb-K®-transgenic	NULL
mice	NULL
that	NULL
express	NULL
the	NULL
H-2K	NULL
``	NULL
transgene	NULL
only	NULL
on	NULL
hepatocytes	NULL
(	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
)	NULL
or	NULL
nontransgenic	NULL
control	NULL
mice	NULL
(	NULL
Des-	NULL
>	NULL
B10.BR	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
fate	NULL
of	NULL
autoreactive	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
number	NULL
of	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
Des-	NULL
>	NULL
B10.BR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
adoptive	NULL
transfer	NULL
.	NULL

The	NULL
representation	NULL
of	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
when	NULL
injected	NULL
into	NULL
control	NULL
B10.BR	NULL
mice	NULL
remained	NULL
fairly	NULL
constant	NULL
over	NULL
the	NULL
50-day	NULL
period	NULL
of	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

On	NULL
average	NULL
,	NULL
the	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
represented	NULL
3	NULL
%	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
of	NULL
the	NULL
total	NULL
spleen	NULL
population	NULL
of	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
.	NULL

For	NULL
the	NULL
first	NULL
10	NULL
days	NULL
following	NULL
transfer	NULL
,	NULL
the	NULL
number	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
control	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
starting	NULL
around	NULL
day	NULL
11	NULL
after	NULL
injection	NULL
,	NULL
the	NULL
number	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
slowly	NULL
de-creased	NULL
,	NULL
and	NULL
~90	NULL
%	NULL
of	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
``	NULL
T	NULL
cells	NULL
had	NULL
disappeared	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
by	NULL
day	NULL
49	NULL
after	NULL
transfer	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
the	NULL
Alb-K®	NULL
mice	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
H-2K	NULL
``	NULL
Ag	NULL
by	NULL
hepatocytes	NULL
may	NULL
induce	NULL
deletion	NULL
of	NULL
the	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
vivo	NULL
activation	NULL
of	NULL
the	NULL
self-reactive	NULL
CD8	NULL
Des	NULL
T	NULL
cells	NULL
Deletion	NULL
of	NULL
autoreactive	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
several	NULL
models	NULL
of	NULL
peripheral	NULL
T	NULL
cell	NULL
tolerance	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
deletion	NULL
was	NULL
preceded	NULL
by	NULL
a	NULL
transient	NULL
phase	NULL
of	NULL
autoimmunity	NULL
and	NULL
proliferation	NULL
of	NULL
the	NULL
autoreactive	NULL
T	NULL
cells	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
determined	NULL
whether	NULL
in	NULL
our	NULL
model	NULL
,	NULL
too	NULL
,	NULL
disappearance	NULL
of	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
T	NULL
cells	NULL
from	NULL
the	NULL
spleen	NULL
was	NULL
preceded	NULL
by	NULL
transient	NULL
activation	NULL
of	NULL
the	NULL
autoreactive	NULL
T	NULL
cells	NULL
.	NULL

Histological	NULL
analysis	NULL
showed	NULL
that	NULL
livers	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K®	NULL
mice	NULL
,	NULL
but	NULL
not	NULL
livers	NULL
from	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
,	NULL
were	NULL
infiltrated	NULL
from	NULL
day	NULL
2	NULL
to	NULL
6	NULL
after	NULL
transfer	NULL
.	NULL

However	NULL
,	NULL
the	NULL
infiltration	NULL
was	NULL
transient	NULL
and	NULL
limited	NULL
to	NULL
the	NULL
portal	NULL
triads	NULL
with	NULL
minor	NULL
invasion	NULL
through	NULL
20	NULL
-e-	NULL
Des-	NULL
>	NULL
Alb-KP	NULL
«	NULL
-o-	NULL
Des-	NULL
>	NULL
B10.BR	NULL
&	NULL
|	NULL
s	NULL
z	NULL
15	NULL
Iffx	NULL
‘	NULL
xx	NULL
3	NULL
a	NULL
2	NULL
f	NULL
§+°	NULL
10	NULL
a=	NULL
$	NULL
®	NULL
=	NULL
O	NULL
2	NULL
ta	NULL
5	NULL
O	NULL
0	NULL
50	NULL
40	NULL
15	NULL
20	NULL
25	NULL
30	NULL
35	NULL
40	NULL
45	NULL
50	NULL
Days	NULL
post-transfer	NULL
FIGURE	NULL
1	NULL
.	NULL

Disappearance	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
following	NULL
transfer	NULL
into	NULL
Alb-K®-transgenic	NULL
mice	NULL
.	NULL

Control	NULL
B10.BR-	NULL
(	NULL
O	NULL
)	NULL
or	NULL
Alb-K®-	NULL
(	NULL
@	NULL
)	NULL
transgenic	NULL
mice	NULL
were	NULL
adult	NULL
thymectomized	NULL
,	NULL
irradiated	NULL
,	NULL
and	NULL
i.v	NULL
.	NULL

injected	NULL
with	NULL
6-8	NULL
x	NULL
10°	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-transgenic	NULL
mice	NULL
.	NULL

At	NULL
different	NULL
time	NULL
points	NULL
after	NULL
adoptive	NULL
transfer	NULL
,	NULL
the	NULL
numbers	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
spleens	NULL
of	NULL
the	NULL
recipient	NULL
mice	NULL
were	NULL
determined	NULL
by	NULL
FACS	NULL
staining	NULL
.	NULL

For	NULL
each	NULL
time	NULL
point	NULL
,	NULL
10-20	NULL
mice	NULL
were	NULL
analyzed	NULL
except	NULL
for	NULL
days	NULL
22	NULL
,	NULL
28	NULL
,	NULL
and	NULL
49	NULL
,	NULL
on	NULL
which	NULL
3-5	NULL
animals	NULL
were	NULL
tested	NULL
.	NULL

The	NULL
mean	NULL
value	NULL
and	NULL
SD	NULL
are	NULL
shown	NULL
.	NULL

4401	NULL
out	NULL
the	NULL
lobules	NULL
and	NULL
no	NULL
evidence	NULL
of	NULL
tissue	NULL
damage	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
further	NULL
characterized	NULL
the	NULL
liver-infiltrating	NULL
cells	NULL
by	NULL
FACS	NULL
staining	NULL
of	NULL
mononuclear	NULL
cells	NULL
isolated	NULL
from	NULL
livers	NULL
of	NULL
Des-	NULL
>	NULL
B10.BR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
.	NULL

Infiltrates	NULL
from	NULL
Des-B10.BR	NULL
liver	NULL
contained	NULL
few	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
none	NULL
of	NULL
which	NULL
expressed	NULL
the	NULL
early	NULL
and	NULL
late	NULL
activation	NULL
markers	NULL
CD69	NULL
and	NULL
CD44	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
an	NULL
accumulation	NULL
of	NULL
CD8	NULL
*	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
livers	NULL
of	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
,	NULL
all	NULL
of	NULL
which	NULL
expressed	NULL
the	NULL
activation	NULL
markers	NULL
CD69	NULL
and	NULL
CD44	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Starting	NULL
at	NULL
day	NULL
5	NULL
after	NULL
transfer	NULL
,	NULL
2-3	NULL
days	NULL
after	NULL
the	NULL
beginning	NULL
of	NULL
liver	NULL
infiltration	NULL
,	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
``	NULL
T	NULL
cells	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
expressed	NULL
CD44	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
that	NULL
expressed	NULL
CD44	NULL
*	NULL
further	NULL
increased	NULL
thereafter	NULL
,	NULL
with	NULL
most	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
being	NULL
CD44	NULL
*	NULL
by	NULL
day	NULL
6	NULL
after	NULL
transfer	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
liver-infiltrating	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
did	NULL
not	NULL
express	NULL
the	NULL
early	NULL
activation	NULL
marker	NULL
CD69	NULL
that	NULL
is	NULL
only	NULL
transiently	NULL
expressed	NULL
by	NULL
stimulated	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

No	NULL
change	NULL
in	NULL
the	NULL
level	NULL
of	NULL
CD25	NULL
and	NULL
CD62	NULL
ligand	NULL
expression	NULL
by	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
B10.BR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
was	NULL
detectable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
€D69	NULL
and	NULL
CD44	NULL
expression	NULL
suggest	NULL
that	NULL
,	NULL
upon	NULL
injection	NULL
into	NULL
Alb-K	NULL
``	NULL
mice	NULL
,	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
rapidly	NULL
homed	NULL
to	NULL
the	NULL
liver	NULL
,	NULL
where	NULL
they	NULL
were	NULL
stimulated	NULL
by	NULL
H-2K	NULL
``	NULL
-expressing	NULL
hepatocytes	NULL
,	NULL
and	NULL
the	NULL
activated	NULL
T	NULL
cells	NULL
then	NULL
returned	NULL
to	NULL
the	NULL
spleen	NULL
.	NULL

We	NULL
further	NULL
determined	NULL
whether	NULL
stimulation	NULL
by	NULL
H-2K®-expressing	NULL
liver	NULL
cells	NULL
induced	NULL
the	NULL
proliferation	NULL
of	NULL
the	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
cell	NULL
division	NULL
can	NULL
be	NULL
measured	NULL
with	NULL
the	NULL
fluorescent	NULL
dye	NULL
CFSE	NULL
,	NULL
which	NULL
distributes	NULL
equally	NULL
between	NULL
the	NULL
two	NULL
daughter	NULL
cells	NULL
at	NULL
every	NULL
division	NULL
,	NULL
thus	NULL
resulting	NULL
in	NULL
a	NULL
2-fold	NULL
reduction	NULL
of	NULL
the	NULL
fluorescence	NULL
intensity	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
Des	NULL
T	NULL
cells	NULL
were	NULL
CFSE-labeled	NULL
before	NULL
transfer	NULL
into	NULL
recipient	NULL
mice	NULL
.	NULL

When	NULL
injected	NULL
into	NULL
control	NULL
B10.BR	NULL
mice	NULL
,	NULL
most	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
had	NULL
not	NULL
divided	NULL
,	NULL
and	NULL
some	NULL
divided	NULL
up	NULL
to	NULL
two	NULL
times	NULL
within	NULL
the	NULL
12	NULL
days	NULL
of	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
recent	NULL
observation	NULL
that	NULL
peripheral	NULL
T	NULL
cells	NULL
maintain	NULL
a	NULL
low	NULL
rate	NULL
of	NULL
division	NULL
induced	NULL
by	NULL
interaction	NULL
of	NULL
their	NULL
TCR	NULL
with	NULL
self	NULL
MHC/peptide	NULL
complexes	NULL
(	NULL
35-37	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD8	NULL
``	NULL
Des	NULL
``	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
had	NULL
divided	NULL
multiple	NULL
times	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

By	NULL
day	NULL
6	NULL
after	NULL
transfer	NULL
,	NULL
50	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
had	NULL
accomplished	NULL
more	NULL
than	NULL
three	NULL
divisions	NULL
,	NULL
and	NULL
some	NULL
divided	NULL
seven	NULL
times	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
that	NULL
accomplished	NULL
several	NULL
divisions	NULL
expressed	NULL
CD44	NULL
and	NULL
are	NULL
thus	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
likely	NULL
infiltrated	NULL
the	NULL
liver	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
H-2K®-expressing	NULL
hepatocytes	NULL
stimulated	NULL
and	NULL
induced	NULL
proliferation	NULL
of	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
despite	NULL
a	NULL
high	NULL
rate	NULL
of	NULL
division	NULL
,	NULL
the	NULL
number	NULL
of	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
was	NULL
not	NULL
significantly	NULL
increased	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
Des-	NULL
>	NULL
B10.BR	NULL
at	NULL
day	NULL
6	NULL
or	NULL
9	NULL
after	NULL
transfer	NULL
,	NULL
suggesting	NULL
that	NULL
deletion	NULL
may	NULL
already	NULL
be	NULL
occurring	NULL
.	NULL

Importantly	NULL
,	NULL
at	NULL
no	NULL
time	NULL
point	NULL
did	NULL
we	NULL
detect	NULL
a	NULL
significant	NULL
down-modulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TCR	NULL
or	NULL
CD8	NULL
coreceptor	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
described	NULL
in	NULL
several	NULL
other	NULL
models	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
an	NULL
increase	NULL
in	NULL
dying	NULL
or	NULL
apoptotic	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
Alb-K	NULL
``	NULL
mice	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
B10.BR	NULL
mice	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
number	NULL
of	NULL
apoptotic	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
as	NULL
detected	NULL
by	NULL
annexinV	NULL
and	NULL
propidium	NULL
iodide	NULL
staining	NULL
was	NULL
comparable	NULL
in	NULL
control	NULL
B10.BR	NULL
mice	NULL
and	NULL
transgenic	NULL
Alb-K°	NULL
mice	NULL
at	NULL
day	NULL
6	NULL
and	NULL
9	NULL
after	NULL
transfer	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
CD8	NULL
Des	NULL
T	NULL
cells	NULL
in	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
is	NULL
not	NULL
resulting	NULL
from	NULL
reduced	NULL
expression	NULL
of	NULL
Bcel-2	NULL
or	NULL
Bcl-x	NULL
,	NULL
The	NULL
anti-apoptotic	NULL
molecules	NULL
Bel-2	NULL
and	NULL
Bel-x	NULL
,	NULL
,	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
survival	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
prevents	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
activated	NULL
in	NULL
the	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4402	NULL
A	NULL
)	NULL
Liver	NULL
infiltrating	NULL
ceils	NULL
Atb-kP	NULL
B10.BR	NULL
1.62	NULL
%	NULL
$	NULL
/m	NULL
ut	NULL
Sot	NULL
an	NULL
!	NULL

m	NULL
;	NULL
me	NULL
ant	NULL
CDs	NULL
PE	NULL
C	NULL
)	NULL
CD8*Des*	NULL
T	NULL
cells	NULL
D=12	NULL
Des	NULL
-	NULL
>	NULL
B1OBR	NULL
Des	NULL
-	NULL
>	NULL
Atb-K®	NULL
~	NULL
Propidium	NULL
lodide	NULL
r	NULL
ANNEXIN	NULL
5	NULL
REGULATION	NULL
OF	NULL
AP-1	NULL
AND	NULL
NF-	NULL
«	NULL
B	NULL
DURING	NULL
CD8	NULL
T	NULL
CELL	NULL
TOLERANCE	NULL
B	NULL
)	NULL
Splenocytes	NULL
_m	NULL
:	NULL
--	NULL
Des-	NULL
>	NULL
B10.BR	NULL
#	NULL
-Des	NULL
Des	NULL
TC	NULL
wow	NULL
an	NULL
Cut	NULL
o	NULL
'ovire	NULL
``	NULL
ﬁ	NULL
'	NULL
l	NULL
‘	NULL
Désiré	NULL
|	NULL
4	NULL
i	NULL
|	NULL
1	NULL
ha	NULL
wove	NULL
ont	NULL
ches	NULL
FITC	NULL
203	NULL
os	NULL
FIGURE	NULL
2	NULL
.	NULL

CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
are	NULL
activated	NULL
.	NULL

A	NULL
,	NULL
Liver-infiltrating	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
4	NULL
days	NULL
after	NULL
transfer	NULL
from	NULL
four	NULL
control	NULL
Des-B10.BR	NULL
(	NULL
thin	NULL
line	NULL
)	NULL
or	NULL
4	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
transgenic	NULL
(	NULL
thick	NULL
line	NULL
)	NULL
mice	NULL
.	NULL

Cells	NULL
were	NULL
triple	NULL
stained	NULL
for	NULL
Des-Tricolor	NULL
,	NULL
CD8-PE	NULL
,	NULL
and	NULL
CD69-FITC	NULL
or	NULL
CD44-FITC	NULL
as	NULL
indicated	NULL
.	NULL

Double-positive	NULL
CD8	NULL
*Des*	NULL
cells	NULL
were	NULL
gated	NULL
(	NULL
R1	NULL
)	NULL
and	NULL
analyzed	NULL
for	NULL
CD69	NULL
and	NULL
CD44	NULL
expression	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
double-positive	NULL
CD8	NULL
*Des	NULL
*	NULL
cells	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
dot	NULL
plots	NULL
.	NULL

Total	NULL
recovery	NULL
from	NULL
four	NULL
livers	NULL
was	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
(	NULL
3.2	NULL
X	NULL
10°	NULL
CD8	NULL
*Des*	NULL
)	NULL
and	NULL
2.4	NULL
X	NULL
10°	NULL
(	NULL
2.8	NULL
%	NULL
10	NULL
%	NULL
CD8	NULL
*Des	NULL
*	NULL
)	NULL
for	NULL
Des-	NULL
>	NULL
B10.BR	NULL
and	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
,	NULL
respectively	NULL
.	NULL

Similar	NULL
profiles	NULL
and	NULL
recoveries	NULL
were	NULL
observed	NULL
at	NULL
days	NULL
5	NULL
and	NULL
6	NULL
.	NULL

B	NULL
,	NULL
Control	NULL
B10.BR	NULL
or	NULL
transgenic-Alb-K	NULL
``	NULL
mice	NULL
were	NULL
transferred	NULL
with	NULL
either	NULL
unlabeled	NULL
(	NULL
Des	NULL
,	NULL
two	NULL
left-side	NULL
histograms	NULL
)	NULL
or	NULL
CFSE-labeled	NULL
(	NULL
Des/CFSE	NULL
,	NULL
right-side	NULL
histograms	NULL
)	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
the	NULL
Des-transgenic	NULL
mice	NULL
.	NULL

The	NULL
splenocytes	NULL
were	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
B10.BR	NULL
(	NULL
hin	NULL
line	NULL
)	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
(	NULL
thick	NULL
line	NULL
)	NULL
mice	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
transfer	NULL
.	NULL

Splenocytes	NULL
from	NULL
mice	NULL
that	NULL
received	NULL
unlabeled	NULL
T	NULL
cells	NULL
(	NULL
Des	NULL
)	NULL
were	NULL
triple-stained	NULL
and	NULL
analyzed	NULL
as	NULL
in	NULL
A.	NULL
Splenocytes	NULL
from	NULL
mice	NULL
that	NULL
received	NULL
CFSE-labeled	NULL
T	NULL
cells	NULL
(	NULL
Des/CFSE	NULL
)	NULL
were	NULL
stained	NULL
with	NULL
Des-Tricolor	NULL
and	NULL
CD8-PE	NULL
.	NULL

Double-positive	NULL
CD8	NULL
*Des*	NULL
cells	NULL
were	NULL
gated	NULL
(	NULL
R1	NULL
)	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
intensity	NULL
of	NULL
CFSE	NULL
staining	NULL
.	NULL

C	NULL
,	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
at	NULL
day	NULL
9	NULL
after	NULL
transfer	NULL
from	NULL
Des-	NULL
>	NULL
B1OBR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
and	NULL
stained	NULL
with	NULL
Cy-5-conjugated	NULL
annexin	NULL
V	NULL
and	NULL
propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
that	NULL
are	NULL
alive	NULL
(	NULL
annexin	NULL
V~PI~	NULL
)	NULL
,	NULL
apoptotic	NULL
(	NULL
annexin	NULL
V	NULL
*PIC	NULL
)	NULL
,	NULL
or	NULL
dead	NULL
(	NULL
annexin	NULL
V	NULL
*PI*	NULL
)	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
corresponding	NULL
gate	NULL
.	NULL

absence	NULL
of	NULL
CD28-dependent	NULL
costimulatory	NULL
signal	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Bel-2	NULL
or	NULL
Bel-x	NULL
,	NULL
_	NULL
also	NULL
prevents	NULL
the	NULL
in	NULL
vivo	NULL
deletion	NULL
of	NULL
mature	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
peptide	NULL
Ag	NULL
(	NULL
40	NULL
)	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
Bel-2	NULL
nor	NULL
Bel-x	NULL
,	NULL
,	NULL
prevent	NULL
the	NULL
decline	NULL
of	NULL
Ag-specific	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
after	NULL
viral	NULL
infection	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
deletion	NULL
of	NULL
the	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
in	NULL
Alb-K	NULL
``	NULL
mice	NULL
resulted	NULL
from	NULL
abnormal	NULL
expression	NULL
of	NULL
either	NULL
the	NULL
Bel-2	NULL
or	NULL
Bel-x	NULL
,	NULL
,	NULL
protein	NULL
.	NULL

The	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
Bel-2	NULL
and	NULL
Bel-x	NULL
,	NULL
,	NULL
proteins	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
prepared	NULL
from	NULL
CD8	NULL
``	NULL
Des	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
B1O0.BR	NULL
mice	NULL
,	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
,	NULL
or	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
primed	NULL
in	NULL
vivo	NULL
with	NULL
H-2K	NULL
``	NULL
®-expressing	NULL
APC	NULL
's	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
level	NULL
of	NULL
Bel-2	NULL
and	NULL
Bel-x	NULL
,	NULL
,	NULL
protein	NULL
expression	NULL
was	NULL
comparable	NULL
in	NULL
the	NULL
different	NULL
population	NULL
,	NULL
indicating	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
is	NULL
not	NULL
resulting	NULL
from	NULL
reduced	NULL
expression	NULL
of	NULL
either	NULL
of	NULL
these	NULL
two	NULL
antiapoptotic	NULL
proteins	NULL
.	NULL

CD8	NULL
*	NULL
Des	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des	NULL
Alb-K	NULL
``	NULL
mice	NULL
are	NULL
unresponsive	NULL
to	NULL
in	NULL
vitro	NULL
restimulation	NULL
Despite	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
the	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
in	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
,	NULL
we	NULL
detected	NULL
no	NULL
sign	NULL
of	NULL
liver	NULL
damage	NULL
or	NULL
autoimmune	NULL
disease	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
was	NULL
transient	NULL
,	NULL
followed	NULL
by	NULL
T	NULL
cell	NULL
tolerance	NULL
.	NULL

One	NULL
would	NULL
predict	NULL
,	NULL
then	NULL
,	NULL
that	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
recolonizing	NULL
the	NULL
spleen	NULL
should	NULL
be	NULL
tolerant	NULL
and	NULL
thus	NULL
unresponsive	NULL
to	NULL
in	NULL
vitro	NULL
restimulation	NULL
with	NULL
H-2K	NULL
``	NULL
-expressing	NULL
APCs	NULL
.	NULL

Indeed	NULL
,	NULL
splenocytes	NULL
from	NULL
Alb-K	NULL
``	NULL
mice	NULL
responded	NULL
very	NULL
poorly	NULL
to	NULL
H-2K	NULL
``	NULL
®-expressing	NULL
APC	NULL
's	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Proliferation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
production	NULL
by	NULL
in	NULL
vitro	NULL
stimulated	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
was	NULL
reduced	NULL
by	NULL
day	NULL
5	NULL
and	NULL
almost	NULL
completely	NULL
abrogated	NULL
by	NULL
day	NULL
11	NULL
after	NULL
transfer	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
CD44	NULL
``	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
reflecting	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
by	NULL
H-2K	NULL
``	NULL
-expressing	NULL
hepatocytes	NULL
)	NULL
increased	NULL
,	NULL
the	NULL
unresponsiveness	NULL
augmented	NULL
(	NULL
compare	NULL
Figs	NULL
.	NULL

2B	NULL
and	NULL
4	NULL
)	NULL
.	NULL

We	NULL
could	NULL
not	NULL
detect	NULL
IL-4	NULL
production	NULL
by	NULL
these	NULL
unresponsive	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
appear	NULL
unresponsive	NULL
to	NULL
further	NULL
in	NULL
vitro	NULL
stimulation	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
T	NULL
cells	NULL
will	NULL
be	NULL
considered	NULL
as	NULL
tolerant	NULL
by	NULL
contrast	NULL
with	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
control	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
,	NULL
which	NULL
will	NULL
be	NULL
considered	NULL
as	NULL
naive	NULL
.	NULL

In	NULL
vitro	NULL
unresponsiveness	NULL
of	NULL
CD8	NULL
Des	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des	NULL
Alb-K	NULL
``	NULL
mice	NULL
correlates	NULL
with	NULL
a	NULL
reduced	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
The	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
participate	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
and	NULL
are	NULL
two	NULL
known	NULL
molecular	NULL
targets	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
anergy	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
stimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD28	NULL
costimulation	NULL
or	NULL
in	NULL
vivo	NULL
by	NULL
repeated	NULL
injection	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Day	NULL
5	NULL
Day	NULL
9	NULL
}	NULL
}	NULL
Des	NULL
-	NULL
>	NULL
B10.BR	NULL
Des	NULL
-	NULL
>	NULL
Alb-KP	NULL
Des	NULL
-	NULL
>	NULL
B10.BR	NULL
Des	NULL
-	NULL
>	NULL
Alb-KP	NULL
Des	NULL
Primed	NULL
Des	NULL
Primed	NULL
Bory	NULL
,	NULL
®m	NULL
@	NULL
@	NULL
jmn	NULL
m	NULL
aan	NULL
)	NULL
~~	NULL
]	NULL
10	NULL
13	NULL
9	NULL
10	NULL
15	NULL
8	NULL
Bcl-2	NULL
26	NULL
4.1	NULL
27	NULL
29	NULL
45	NULL
42	NULL
Actin	NULL
FIGURE	NULL
3	NULL
.	NULL

Deletion	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
in	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
does	NULL
not	NULL
result	NULL
from	NULL
reduced	NULL
expression	NULL
of	NULL
Bel-2	NULL
or	NULL
Bcl-x	NULL
,	NULL
.	NULL

CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
either	NULL
Des-	NULL
>	NULL
B10.BR	NULL
or	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K®	NULL
mice	NULL
at	NULL
day	NULL
5	NULL
or	NULL
9	NULL
after	NULL
transfer	NULL
.	NULL

Similarly	NULL
,	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
Des-B10.BR	NULL
mice	NULL
at	NULL
day	NULL
5	NULL
or	NULL
9	NULL
after	NULL
priming	NULL
with	NULL
H-2K®-expressing-APCs	NULL
(	NULL
Des	NULL
primed	NULL
)	NULL
.	NULL

Eight	NULL
to	NULL
ten	NULL
micrograms	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
Western	NULL
blotting	NULL
,	NULL
and	NULL
the	NULL
different	NULL
blots	NULL
were	NULL
revealed	NULL
with	NULL
Bcl-x	NULL
;	NULL
,	NULL
Bcl-2	NULL
,	NULL
and	NULL
actin-specific	NULL
Abs	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
quantified	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
values	NULL
corrected	NULL
for	NULL
loading	NULL
differences	NULL
using	NULL
the	NULL
actin	NULL
control	NULL
are	NULL
indicated	NULL
.	NULL

of	NULL
superantigen	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
unresponsiveness	NULL
in	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cell	NULL
population	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
induced	NULL
by	NULL
in	NULL
vitro	NULL
restimulation	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

To	NULL
directly	NULL
measure	NULL
transcriptional	NULL
activity	NULL
,	NULL
we	NULL
used	NULL
two	NULL
different	NULL
lines	NULL
of	NULL
transgenic	NULL
mice	NULL
that	NULL
express	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
either	NULL
AP-1	NULL
(	NULL
AP-1-Luc	NULL
)	NULL
(	NULL
11	NULL
)	NULL
or	NULL
NF-KB	NULL
sites	NULL
(	NULL
NF-	NULL
«	NULL
B-Luc	NULL
)	NULL
(	NULL
28	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
AP-1-Luc-transgenic	NULL
mice	NULL
directly	NULL
reflects	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
(	NULL
11	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B-Luc-transgenic	NULL
mice	NULL
directly	NULL
reflects	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
.	NULL

Indeed	NULL
,	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B-Luc	NULL
mice	NULL
is	NULL
only	NULL
detected	NULL
in	NULL
tissues	NULL
that	NULL
demonstrate	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
luciferase	NULL
reporter	NULL
activity	NULL
is	NULL
constituvely	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
subpopu-lations	NULL
of	NULL
thymocytes	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
it	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
by	NULL
known	NULL
inducers	NULL
of	NULL
NF-KB	NULL
(	NULL
(	NULL
28	NULL
,	NULL
42-44	NULL
)	NULL
and	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Mice	NULL
transgenic	NULL
for	NULL
the	NULL
Des	NULL
TCR	NULL
were	NULL
thus	NULL
crossed	NULL
with	NULL
either	NULL
the	NULL
AP-1-Luc	NULL
(	NULL
AP-1	NULL
X	NULL
Des	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B-Luc	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
X	NULL
Des	NULL
)	NULL
transgenic	NULL
mice	NULL
,	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
double-transgenic	NULL
mice	NULL
were	NULL
injected	NULL
into	NULL
either	NULL
B10.BR	NULL
or	NULL
Alb-K®	NULL
mice	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
stimulation	NULL
of	NULL
~	NULL
IFN	NULL
It-2	NULL
Y	NULL
[	NULL
J	NULL
Des-	NULL
>	NULL
B10.BR	NULL
NJ	NULL
Des-	NULL
>	NULL
Aib-KP	NULL
IL2	NULL
(	NULL
U/mi	NULL
)	NULL
yIFN	NULL
(	NULL
U/ml	NULL
)	NULL
64	NULL
%	NULL
100	NULL
%	NULL
d=5	NULL
d=11	NULL
FIGURE	NULL
4	NULL
.	NULL

Partial	NULL
unresponsiveness	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
.	NULL

Splenocytes	NULL
from	NULL
Des-	NULL
>	NULL
B10.BR-	NULL
or	NULL
Des-	NULL
Alb-K®-transgenic	NULL
mice	NULL
were	NULL
restimulated	NULL
in	NULL
vitro	NULL
with	NULL
B10.BR	NULL
or	NULL
H-2K®-expressing	NULL
CBK	NULL
splenocytes	NULL
.	NULL

Groups	NULL
of	NULL
three	NULL
and	NULL
five	NULL
mice	NULL
were	NULL
tested	NULL
at	NULL
days	NULL
5	NULL
and	NULL
11	NULL
after	NULL
transfer	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
total	NULL
of	NULL
4	NULL
X	NULL
10°	NULL
splenocytes	NULL
(	NULL
8-12	NULL
x	NULL
10	NULL
%	NULL
CD8	NULL
*Des	NULL
*	NULL
)	NULL
were	NULL
stimulated	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
collected	NULL
at	NULL
24	NULL
h	NULL
and	NULL
48	NULL
h	NULL
after	NULL
activation	NULL
to	NULL
measure	NULL
IL-2	NULL
production	NULL
and	NULL
yIFEN	NULL
production	NULL
,	NULL
respectively	NULL
.	NULL

Because	NULL
the	NULL
representation	NULL
of	NULL
CD8	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
different	NULL
populations	NULL
analyzed	NULL
varied	NULL
slightly	NULL
,	NULL
we	NULL
normalized	NULL
all	NULL
the	NULL
responses	NULL
to	NULL
1	NULL
X	NULL
10°	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
values	NULL
presented	NULL
are	NULL
these	NULL
corrected	NULL
values	NULL
.	NULL

The	NULL
percentage	NULL
in	NULL
the	NULL
different	NULL
graphs	NULL
refers	NULL
to	NULL
the	NULL
reduction	NULL
of	NULL
the	NULL
response	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
at	NULL
4	NULL
(	NULL
three	NULL
experiments	NULL
)	NULL
,	NULL
5	NULL
(	NULL
two	NULL
experiments	NULL
)	NULL
,	NULL
6	NULL
(	NULL
one	NULL
experiment	NULL
)	NULL
,	NULL
and	NULL
10-12	NULL
(	NULL
four	NULL
experiments	NULL
)	NULL
days	NULL
.	NULL

4403	NULL
A	NULL
)	NULL
Ex-vivo	NULL
cells	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
activated	NULL
CD4+	NULL
T	NULL
cells	NULL
24h	NULL
600	NULL
400	NULL
200	NULL
0	NULL
'	NULL
B	NULL
-	NULL
CDB+T	NULL
PJ	NULL
.	NULL

o-CD3	NULL
o-CD3	NULL
a-CD28	NULL
cells	NULL
-	NULL
cells	NULL
FIGURE	NULL
5	NULL
.	NULL

Regulation	NULL
of	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
in	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
The	NULL
luciferase	NULL
activity	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
naive	NULL
B	NULL
or	NULL
T	NULL
cells	NULL
from	NULL
NF-xB-Luc	NULL
was	NULL
analyzed	NULL
.	NULL

B	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
NF-	NULL
«	NULL
B-Luc	NULL
single-transgenic	NULL
mice	NULL
and	NULL
stimulated	NULL
with	NULL
either	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
iono-mycin	NULL
(	NULL
250	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
PI	NULL
)	NULL
or	NULL
plate-bound	NULL
anti-CD3	NULL
(	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
soluble	NULL
anti-CD28	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
luciferase	NULL
activity	NULL
mea-sured	NULL
.	NULL

Syngeneic	NULL
response	NULL
(	NULL
subtracted	NULL
)	NULL
did	NULL
not	NULL
exceed	NULL
25	NULL
RLU	NULL
.	NULL

naive	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
with	NULL
H-2K®-expressing	NULL
APCs	NULL
induced	NULL
both	NULL
AP-1	NULL
and	NULL
NF-B	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
induced	NULL
by	NULL
in	NULL
vitro	NULL
stimulation	NULL
of	NULL
the	NULL
tolerant	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
was	NULL
reduced	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
naive	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
overall	NULL
reduction	NULL
in	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
was	NULL
comparable	NULL
to	NULL
the	NULL
reduction	NULL
of	NULL
cytokine	NULL
production	NULL
(	NULL
compare	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
unresponsive	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
to	NULL
produce	NULL
cytokines	NULL
upon	NULL
TCR	NULL
signaling	NULL
in	NULL
vitro	NULL
correlates	NULL
with	NULL
a	NULL
reduced	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
,	NULL
further	NULL
suggesting	NULL
that	NULL
unresponsive	NULL
CD8	NULL
*	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
have	NULL
a	NULL
defect	NULL
on	NULL
the	NULL
TCR	NULL
signaling	NULL
pathway	NULL
.	NULL

A	NULL
)	NULL
AP-1	NULL
CBK	NULL
ConA	NULL
400	NULL
[	NULL
d	NULL
Des-	NULL
>	NULL
B10.BR	NULL
300	NULL
M	NULL
Des-	NULL
>	NULL
Alb-KP	NULL
200	NULL
77	NULL
%	NULL
100	NULL
a	NULL
24h	NULL
B	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
CBK	NULL
ConA	NULL
2000	NULL
600	NULL
l	NULL
400	NULL
l	NULL
@	NULL
1000	NULL
g	NULL
JP	NULL
2	NULL
24h	NULL
48h	NULL
72h	NULL
24h	NULL
FIGURE	NULL
6	NULL
.	NULL

Tolerized	NULL
T	NULL
cells	NULL
present	NULL
a	NULL
reduced	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
after	NULL
in	NULL
vitro	NULL
restimulation	NULL
.	NULL

Des-	NULL
>	NULL
B10.BR	NULL
(	NULL
@	NULL
)	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K®	NULL
(	NULL
MM	NULL
)	NULL
mice	NULL
were	NULL
injected	NULL
with	NULL
Des*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
AP-1	NULL
X	NULL
Des	NULL
(	NULL
A	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
X	NULL
Des	NULL
(	NULL
B	NULL
)	NULL
double-transgenic	NULL
mice	NULL
.	NULL

At	NULL
day	NULL
5	NULL
after	NULL
transfer	NULL
,	NULL
12	NULL
X	NULL
10°	NULL
splenocytes	NULL
were	NULL
stimulated	NULL
with	NULL
syngeneic	NULL
B10.BR	NULL
APCs	NULL
,	NULL
H-2K	NULL
``	NULL
-expressing	NULL
CBK	NULL
APCs	NULL
,	NULL
or	NULL
Con	NULL
A	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
B10.BR	NULL
APCs	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
luciferase	NULL
activity	NULL
read	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
was	NULL
determined	NULL
before	NULL
activation	NULL
.	NULL

Using	NULL
this	NULL
value	NULL
,	NULL
the	NULL
RLU	NULL
for	NULL
5	NULL
X	NULL
10°	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
calculated	NULL
and	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Syngeneic	NULL
response	NULL
(	NULL
subtracted	NULL
)	NULL
did	NULL
not	NULL
exceed	NULL
25	NULL
RLU	NULL
.	NULL

The	NULL
percentage	NULL
in	NULL
the	NULL
different	NULL
graphs	NULL
refers	NULL
to	NULL
the	NULL
reduction	NULL
of	NULL
the	NULL
response	NULL
.	NULL

One	NULL
experiment	NULL
of	NULL
two	NULL
for	NULL
AP-1	NULL
activity	NULL
and	NULL
four	NULL
for	NULL
NF-KB	NULL
activity	NULL
is	NULL
shown	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4404	NULL
REGULATION	NULL
OF	NULL
AP-1	NULL
AND	NULL
NF-	NULL
«	NULL
B	NULL
DURING	NULL
CD8	NULL
T	NULL
CELL	NULL
TOLERANCE	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
during	NULL
tolerance	NULL
induction	NULL
in	NULL
vivo	NULL
In	NULL
our	NULL
model	NULL
,	NULL
hepatocytes	NULL
stimulated	NULL
the	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
activation	NULL
was	NULL
transient	NULL
,	NULL
and	NULL
the	NULL
stimulated	NULL
T	NULL
cells	NULL
became	NULL
unresponsive	NULL
and	NULL
likely	NULL
died	NULL
.	NULL

This	NULL
contrasts	NULL
with	NULL
T	NULL
cells	NULL
stimulated	NULL
by	NULL
professional	NULL
APCs	NULL
that	NULL
develop	NULL
into	NULL
effector	NULL
cells	NULL
and	NULL
long-lived	NULL
memory	NULL
cells	NULL
.	NULL

To	NULL
understand	NULL
how	NULL
T	NULL
cell	NULL
fate	NULL
may	NULL
be	NULL
controlled	NULL
in	NULL
these	NULL
two	NULL
situations	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
regulation	NULL
of	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
as	NULL
tolerance	NULL
or	NULL
immunity	NULL
developed	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
tolerant	NULL
T	NULL
cells	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
above	NULL
by	NULL
transfer	NULL
,	NULL
into	NULL
Alb-K®	NULL
mice	NULL
,	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
either	NULL
AP-1	NULL
X	NULL
Des-	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
X	NULL
Des-	NULL
transgenic	NULL
mice	NULL
.	NULL

In	NULL
par-allel	NULL
,	NULL
in	NULL
vivo	NULL
primed	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
cells	NULL
were	NULL
generated	NULL
by	NULL
immunizing	NULL
AP-1	NULL
X	NULL
Des	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
X	NULL
Des	NULL
double-transgenic	NULL
mice	NULL
with	NULL
H-2K	NULL
``	NULL
®-expressing	NULL
APCs	NULL
,	NULL
a	NULL
protocol	NULL
known	NULL
to	NULL
induce	NULL
effector	NULL
and	NULL
memory	NULL
CTLs	NULL
.	NULL

The	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
was	NULL
analyzed	NULL
at	NULL
different	NULL
time	NULL
points	NULL
thereafter	NULL
.	NULL

We	NULL
found	NULL
that	NULL
in	NULL
vivo	NULL
primed	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
exhibited	NULL
a	NULL
low	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
,	NULL
with	NULL
maximal	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
24	NULL
h	NULL
after	NULL
priming	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
vivo	NULL
primed	NULL
T	NULL
cells	NULL
had	NULL
a	NULL
2-	NULL
to	NULL
3-fold	NULL
lower	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
in	NULL
vitro	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Not	NULL
surprisingly	NULL
,	NULL
then	NULL
,	NULL
when	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
or	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
were	NULL
analyzed	NULL
for	NULL
in	NULL
vivo	NULL
AP-1	NULL
or	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
,	NULL
no	NULL
signal	NULL
could	NULL
be	NULL
detected	NULL
using	NULL
this	NULL
enzymatic	NULL
assay	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
used	NULL
RT-PCR	NULL
to	NULL
measure	NULL
luciferase	NULL
mRNA	NULL
expression	NULL
that	NULL
also	NULL
reflects	NULL
AP-1	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
but	NULL
should	NULL
be	NULL
more	NULL
sensitive	NULL
than	NULL
enzymatic	NULL
assays	NULL
.	NULL

Significant	NULL
levels	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
were	NULL
detected	NULL
at	NULL
13	NULL
h	NULL
after	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
transactivation	NULL
declined	NULL
thereafter	NULL
,	NULL
whereas	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
was	NULL
long	NULL
lasting	NULL
and	NULL
still	NULL
clearly	NULL
detectable	NULL
at	NULL
37	NULL
h	NULL
after	NULL
in	NULL
vivo	NULL
priming	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
vivo	NULL
activation	NULL
of	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
an	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Using	NULL
the	NULL
same	NULL
approach	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
level	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
expressed	NULL
by	NULL
CD8	NULL
``	NULL
Des	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
isolated	NULL
at	NULL
different	NULL
time	NULL
points	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K®	NULL
(	NULL
tolerant	NULL
)	NULL
or	NULL
Des-	NULL
>	NULL
B10.BR	NULL
(	NULL
naive	NULL
)	NULL
mice	NULL
.	NULL

The	NULL
tolerant	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
detectable	NULL
levels	NULL
of	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
very	NULL
weak	NULL
AP-1	NULL
signal	NULL
detected	NULL
at	NULL
day	NULL
6	NULL
after	NULL
transfer	NULL
was	NULL
not	NULL
sustained	NULL
at	NULL
day	NULL
11	NULL
or	NULL
12	NULL
after	NULL
transfer	NULL
,	NULL
when	NULL
most	NULL
CD8	NULL
``	NULL
Des	NULL
``	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
are	NULL
tolerant	NULL
.	NULL

Similarly	NULL
,	NULL
at	NULL
the	NULL
early	NULL
time	NULL
point	NULL
when	NULL
no	NULL
tolerant	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
were	NULL
found	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
,	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
B10.BR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
expressed	NULL
no	NULL
significant	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
day	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
tolerant	NULL
T	NULL
cells	NULL
showed	NULL
a	NULL
low	NULL
level	NULL
of	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
.	NULL

Indeed	NULL
,	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
was	NULL
low	NULL
at	NULL
day	NULL
5	NULL
after	NULL
transfer	NULL
,	NULL
when	NULL
only	NULL
15-20	NULL
%	NULL
of	NULL
the	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
were	NULL
CD44*	NULL
(	NULL
tolerant	NULL
)	NULL
and	NULL
increased	NULL
thereafter	NULL
as	NULL
the	NULL
fraction	NULL
of	NULL
tolerant	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
maximal	NULL
level	NULL
of	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
expressed	NULL
by	NULL
tolerant	NULL
T	NULL
cells	NULL
was	NULL
extremely	NULL
low	NULL
and	NULL
remained	NULL
10-	NULL
to	NULL
20-fold	NULL
lower	NULL
than	NULL
the	NULL
NF-B	NULL
transcriptional	NULL
activity	NULL
expressed	NULL
by	NULL
in	NULL
vivo	NULL
primed	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
survival	NULL
correlate	NULL
with	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
,	NULL
whereas	NULL
deletion	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
correlates	NULL
with	NULL
weak	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
undetectable	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

A	NULL
)	NULL
Primed	NULL
CD8*Des*	NULL
T	NULL
cells	NULL
60	NULL
50	NULL
40	NULL
30	NULL
20	NULL
©	NULL
AP-1	NULL
I	NULL
NF-	NULL
«	NULL
B	NULL
Luciferase	NULL
mRNA	NULL
{	NULL
ratio	NULL
Primed	NULL
/	NULL
Unprimed	NULL
)	NULL
13h	NULL
23h	NULL
37h	NULL
Time	NULL
post	NULL
priming	NULL
B	NULL
)	NULL
Tolerant	NULL
CD8*Des*	NULL
T	NULL
cells	NULL
o	NULL
AP1	NULL
e	NULL
NF-xB	NULL
Luciferase	NULL
mRNA	NULL
{	NULL
ratio	NULL
Alb-K®	NULL
/	NULL
B10BR	NULL
)	NULL
2040	NULL
60080	NULL
10	NULL
12	NULL
14	NULL
Days	NULL
post	NULL
transfer	NULL
FIGURE	NULL
7	NULL
.	NULL

AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
expressed	NULL
by	NULL
in	NULL
vivo	NULL
primed	NULL
or	NULL
tolerized	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
AP-1	NULL
X	NULL
Des	NULL
(	NULL
¥	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
X	NULL
Des	NULL
(	NULL
R	NULL
)	NULL
double-transgenic	NULL
mice	NULL
were	NULL
primed	NULL
by	NULL
i.v	NULL
.	NULL

injection	NULL
of	NULL
H-2K	NULL
``	NULL
-expressing	NULL
B	NULL
cell	NULL
blast	NULL
(	NULL
primed	NULL
)	NULL
or	NULL
left	NULL
unimmunized	NULL
(	NULL
unprimed	NULL
)	NULL
.	NULL

At	NULL
different	NULL
time	NULL
points	NULL
after	NULL
immunization	NULL
,	NULL
CD8*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
luciferase	NULL
mRNA	NULL
measured	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
.	NULL

B	NULL
,	NULL
Control	NULL
B10.BR	NULL
or	NULL
Alb-K®-transgenic	NULL
mice	NULL
were	NULL
injected	NULL
with	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
AP-1	NULL
X	NULL
Des	NULL
(	NULL
O	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
X	NULL
Des	NULL
(	NULL
@	NULL
)	NULL
double-transgenic	NULL
mice	NULL
.	NULL

At	NULL
different	NULL
time	NULL
points	NULL
after	NULL
transfer	NULL
,	NULL
CD8*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
luciferase	NULL
mRNA	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
RT-PCR	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
normalized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
amount	NULL
of	NULL
HPRT	NULL
mRNA	NULL
detected	NULL
by	NULL
RT-PCR	NULL
and	NULL
corrected	NULL
for	NULL
the	NULL
number	NULL
of	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
ratio	NULL
of	NULL
(	NULL
A	NULL
)	NULL
the	NULL
amount	NULL
of	NULL
luciferase	NULL
mRNA	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
primed	NULL
mice	NULL
divided	NULL
by	NULL
the	NULL
amount	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
unprimed	NULL
mice	NULL
and	NULL
(	NULL
B	NULL
)	NULL
the	NULL
amount	NULL
of	NULL
luciferase	NULL
mRNA	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
experimental	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
divided	NULL
by	NULL
the	NULL
amount	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
control	NULL
Des-	NULL
>	NULL
B10.BR	NULL
mice	NULL
.	NULL

For	NULL
each	NULL
sample	NULL
,	NULL
the	NULL
reverse	NULL
transcription	NULL
and	NULL
the	NULL
PCR	NULL
were	NULL
run	NULL
in	NULL
duplicates	NULL
and	NULL
the	NULL
average	NULL
of	NULL
the	NULL
four	NULL
measurements	NULL
used	NULL
for	NULL
calculation	NULL
.	NULL

Each	NULL
symbol	NULL
represents	NULL
one	NULL
experimental	NULL
group	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
expressed	NULL
by	NULL
tolerant	NULL
CD8	NULL
Des	NULL
``	NULL
T	NULL
cells	NULL
differ	NULL
from	NULL
those	NULL
of	NULL
naive	NULL
or	NULL
primed	NULL
T	NULL
cells	NULL
We	NULL
further	NULL
examined	NULL
how	NULL
the	NULL
differences	NULL
in	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
detected	NULL
in	NULL
the	NULL
different	NULL
CD8	NULL
*	NULL
Des	NULL
*	NULL
T	NULL
cell	NULL
populations	NULL
may	NULL
correlate	NULL
with	NULL
differences	NULL
in	NULL
the	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
generated	NULL
.	NULL

We	NULL
performed	NULL
EMSA	NULL
on	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
different	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
analyzed	NULL
above	NULL
.	NULL

To	NULL
define	NULL
the	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
induced	NULL
by	NULL
in	NULL
vivo	NULL
priming	NULL
,	NULL
we	NULL
isolated	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
from	NULL
Des-transgenic	NULL
mice	NULL
either	NULL
primed	NULL
5	NULL
h	NULL
earlier	NULL
with	NULL
H-2K	NULL
``	NULL
®-expressing	NULL
APCs	NULL
or	NULL
left	NULL
unprimed	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
a	NULL
tolerogenic	NULL
signal	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
CD8*	NULL
T	NULL
cells	NULL
from	NULL
either	NULL
Des-	NULL
>	NULL
B1O0.BR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
®	NULL
mice	NULL
9	NULL
days	NULL
after	NULL
adoptive	NULL
transfer	NULL
,	NULL
when	NULL
most	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
are	NULL
CD44*	NULL
and	NULL
unresponsive	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
priming	NULL
led	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
AP-1	NULL
complexes	NULL
detected	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
.	NULL

Naive	NULL
and	NULL
tolerant	NULL
T	NULL
cells	NULL
,	NULL
that	NULL
did	NULL
not	NULL
show	NULL
AP-1	NULL
transactivation	NULL
,	NULL
had	NULL
no	NULL
detectable	NULL
AP-1	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
two	NULL
defined	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
were	NULL
present	NULL
in	NULL
unprimed	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
they	NULL
were	NULL
strongly	NULL
up-regulated	NULL
in	NULL
extracts	NULL
isolated	NULL
from	NULL
primed	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
complexes	NULL
N1	NULL
and	NULL
N2	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
)	NULL
AP-1	NULL
D	NULL
)	NULL
NF-xB	NULL
Des	NULL
-	NULL
>	NULL
Alb-K®	NULL
Des	NULL
Primed	NULL
Ab	NULL
:	NULL
-	NULL
p50	NULL
p65	NULL
cRei	NULL
PCS	NULL
p50psscne|P°5	NULL
cRel	NULL
<	NULL
1	NULL
|	NULL
N1	NULL
II	NULL
I	NULL
N2	NULL
III	NULL
<	NULL
IV	NULL
B	NULL
)	NULL
NF-xB	NULL
&	NULL
&	NULL
E4	NULL
&	NULL
.	NULL

4405	NULL
C	NULL
)	NULL
OCT	NULL
a°	NULL
NC	NULL
%	NULL
%	NULL
%	NULL
%	NULL
<	NULL
|	NULL
N1	NULL
1	NULL
N2	NULL
*	NULL
|	NULL
N3	NULL
E	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
Des	NULL
-	NULL
>	NULL
AIb-K®	NULL
Des	NULL
Primed	NULL
-	NULL
p50	NULL
p65	NULL
-	NULL
p50	NULL
p65	NULL
``	NULL
ns	NULL
<	NULL
4	NULL
i	NULL
1	NULL
a	NULL
'..	NULL
m	NULL
S	NULL
<	NULL
IV	NULL
FIGURE	NULL
8	NULL
.	NULL

Tolerant	NULL
T	NULL
cells	NULL
express	NULL
unusual	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
.	NULL

Des-transgenic	NULL
mice	NULL
were	NULL
primed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
(	NULL
primed	NULL
)	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
unprimed	NULL
)	NULL
.	NULL

Five	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
.	NULL

CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
either	NULL
Des-	NULL
>	NULL
B10.BR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K®	NULL
mice	NULL
at	NULL
day	NULL
9	NULL
after	NULL
transfer	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
.	NULL

Three	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
EMSA	NULL
(	NULL
4	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
or	NULL
supershift	NULL
experiments	NULL
(	NULL
D	NULL
and	NULL
£	NULL
)	NULL
using	NULL
an	NULL
AP-1-	NULL
(	NULL
A	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B-	NULL
(	NULL
B	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
)	NULL
,	NULL
or	NULL
consensus	NULL
OCT1	NULL
and	NULL
2-	NULL
(	NULL
C	NULL
)	NULL
specific	NULL
probe	NULL
.	NULL

The	NULL
AP-1	NULL
complex	NULL
present	NULL
in	NULL
the	NULL
``	NULL
Des-primed	NULL
``	NULL
cells	NULL
was	NULL
competed	NULL
with	NULL
a	NULL
cold	NULL
AP-1	NULL
oligonucleotide	NULL
(	NULL
4	NULL
,	NULL
cold	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
Ab	NULL
used	NULL
in	NULL
the	NULL
supershifts	NULL
is	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
(	NULL
D	NULL
and	NULL
E	NULL
)	NULL
.	NULL

Supershifts	NULL
were	NULL
run	NULL
normally	NULL
(	NULL
£	NULL
)	NULL
to	NULL
exemplify	NULL
the	NULL
supershifted	NULL
complexes	NULL
or	NULL
for	NULL
a	NULL
shorter	NULL
period	NULL
(	NULL
D	NULL
)	NULL
to	NULL
exemplify	NULL
the	NULL
lower	NULL
mobility	NULL
complexes	NULL
and	NULL
the	NULL
inhibitions	NULL
of	NULL
the	NULL
corresponding	NULL
complexes	NULL
.	NULL

ns	NULL
,	NULL
Nonspecific	NULL
.	NULL

«	NULL
indicates	NULL
DNA	NULL
binding	NULL
complexes	NULL
and	NULL
<	NULL
I	NULL
,	NULL
the	NULL
supershifted	NULL
complexes	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Variable	NULL
levels	NULL
of	NULL
these	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
were	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
either	NULL
Des-	NULL
>	NULL
B1O.BR	NULL
or	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
.	NULL

Mainly	NULL
complex	NULL
N1	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
some	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
tolerant	NULL
population	NULL
(	NULL
Fig	NULL
.	NULL

8D	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
an	NULL
additional	NULL
complex	NULL
was	NULL
highly	NULL
abundant	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K®	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
complex	NULL
N3	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
present	NULL
in	NULL
primed	NULL
or	NULL
tolerant	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Abs	NULL
specific	NULL
for	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
members	NULL
.	NULL

Supershift	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
primed	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
contain	NULL
p65	NULL
and	NULL
p50	NULL
and	NULL
may	NULL
contain	NULL
c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
D	NULL
and	NULL
FE	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
complex	NULL
N1	NULL
likely	NULL
corresponds	NULL
to	NULL
the	NULL
previously	NULL
reported	NULL
p65/p50	NULL
dimers	NULL
,	NULL
and	NULL
complex	NULL
N2	NULL
contains	NULL
p50/p50	NULL
and	NULL
,	NULL
potentially	NULL
,	NULL
p65/c-Rel	NULL
dimers	NULL
(	NULL
Fig	NULL
.	NULL

8D	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
of	NULL
the	NULL
N3	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
was	NULL
weakly	NULL
inhibited	NULL
by	NULL
p50-specific	NULL
Ab	NULL
and	NULL
completely	NULL
inhibited	NULL
by	NULL
a	NULL
p65-specific	NULL
Ab	NULL
but	NULL
not	NULL
with	NULL
an	NULL
anti-c-Rel	NULL
Ab	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
D	NULL
and	NULL
E	NULL
,	NULL
complexes	NULL
IV	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
neither	NULL
inhibited	NULL
nor	NULL
supershifted	NULL
by	NULL
p65-	NULL
or	NULL
c-Rel-specific	NULL
Abs	NULL
alone	NULL
,	NULL
but	NULL
disappeared	NULL
almost	NULL
completely	NULL
when	NULL
a	NULL
mix	NULL
of	NULL
anti-p65	NULL
and	NULL
anti-c-Rel	NULL
Abs	NULL
was	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
contain	NULL
p65/c-Rel	NULL
heterodimer	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
D	NULL
and	NULL
E	NULL
,	NULL
complexes	NULL
IID	NULL
)	NULL
.	NULL

This	NULL
band	NULL
was	NULL
also	NULL
inhibited	NULL
to	NULL
some	NULL
extent	NULL
by	NULL
p50-specific	NULL
Abs	NULL
and	NULL
may	NULL
therefore	NULL
contain	NULL
p50	NULL
homodimers	NULL
(	NULL
Fig	NULL
.	NULL

8D	NULL
)	NULL
.	NULL

The	NULL
migration	NULL
pattern	NULL
of	NULL
complexes	NULL
III	NULL
and	NULL
IV	NULL
is	NULL
rather	NULL
different	NULL
from	NULL
that	NULL
expected	NULL
from	NULL
p65-containing	NULL
complexes	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
additional	NULL
posttranscriptional	NULL
modifications	NULL
(	NULL
45-47	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
primed	NULL
and	NULL
tolerant	NULL
T	NULL
cells	NULL
that	NULL
show	NULL
high	NULL
and	NULL
weak	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
,	NULL
respectively	NULL
,	NULL
also	NULL
express	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
complexes	NULL
detected	NULL
in	NULL
primed	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
are	NULL
mainly	NULL
p65/p50	NULL
and	NULL
p50/p50	NULL
dimers	NULL
.	NULL

These	NULL
classical	NULL
p50-containing	NULL
complexes	NULL
are	NULL
barely	NULL
detectable	NULL
in	NULL
the	NULL
tolerant	NULL
population	NULL
that	NULL
expresses	NULL
predominantly	NULL
p65-	NULL
and	NULL
c-Rel-containing	NULL
complexes	NULL
that	NULL
may	NULL
correspond	NULL
to	NULL
homo-	NULL
or	NULL
heterodimer	NULL
with	NULL
c-Rel	NULL
.	NULL

Discussion	NULL
As	NULL
an	NULL
approach	NULL
to	NULL
understand	NULL
the	NULL
in	NULL
vivo	NULL
regulation	NULL
of	NULL
the	NULL
fate	NULL
of	NULL
autoreactive	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
developed	NULL
an	NULL
adoptive	NULL
transfer	NULL
protocol	NULL
in	NULL
which	NULL
both	NULL
the	NULL
cellular	NULL
and	NULL
molecular	NULL
mechanisms	NULL
of	NULL
CD8	NULL
*	NULL
T	NULL
cell	NULL
tolerance	NULL
could	NULL
be	NULL
defined	NULL
.	NULL

We	NULL
analyzed	NULL
the	NULL
response	NULL
of	NULL
CD8	NULL
#	NULL
*	NULL
T	NULL
cells	NULL
to	NULL
a	NULL
self	NULL
Ag	NULL
,	NULL
the	NULL
class	NULL
I	NULL
alloantigen	NULL
H-2K	NULL
``	NULL
exclusively	NULL
expressed	NULL
by	NULL
liver	NULL
cells	NULL
.	NULL

Adoptive	NULL
transfer	NULL
of	NULL
mature	NULL
CD8	NULL
``	NULL
Des	NULL
``	NULL
T	NULL
cells	NULL
into	NULL
Alb-K®	NULL
mice	NULL
led	NULL
to	NULL
autoimmunity	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
liver	NULL
infiltration	NULL
observed	NULL
by	NULL
day	NULL
2	NULL
after	NULL
transfer	NULL
.	NULL

However	NULL
,	NULL
the	NULL
autoimmune	NULL
response	NULL
was	NULL
mild	NULL
and	NULL
transient	NULL
and	NULL
tolerance	NULL
fol-lowed	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
found	NULL
no	NULL
evidence	NULL
of	NULL
liver	NULL
damage	NULL
,	NULL
and	NULL
liver	NULL
infiltration	NULL
cleared	NULL
by	NULL
day	NULL
6	NULL
after	NULL
transfer	NULL
.	NULL

Clearly	NULL
,	NULL
hepatocytes	NULL
can	NULL
stimulate	NULL
the	NULL
H-2K®-specific	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
CD69	NULL
and	NULL
CD44	NULL
expression	NULL
and	NULL
the	NULL
proliferation	NULL
of	NULL
the	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
extensive	NULL
proliferation	NULL
,	NULL
the	NULL
number	NULL
of	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
does	NULL
not	NULL
increase	NULL
,	NULL
and	NULL
deletion	NULL
of	NULL
the	NULL
self-reactive	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
is	NULL
evident	NULL
by	NULL
day	NULL
10	NULL
after	NULL
transfer	NULL
.	NULL

Therefore	NULL
,	NULL
tolerance	NULL
in	NULL
this	NULL
model	NULL
is	NULL
likely	NULL
resulting	NULL
from	NULL
an	NULL
abortive	NULL
activation	NULL
by	NULL
hepatocytes	NULL
of	NULL
the	NULL
H-2K®-specific	NULL
T	NULL
cells	NULL
leading	NULL
to	NULL
T	NULL
cell	NULL
death	NULL
,	NULL
as	NULL
previously	NULL
suggested	NULL
by	NULL
Bertolino	NULL
and	NULL
collaborators	NULL
(	NULL
3	NULL
,	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

It	NULL
is	NULL
largely	NULL
believed	NULL
that	NULL
naive	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
generally	NULL
have	NULL
access	NULL
to	NULL
tissue	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
liver	NULL
is	NULL
an	NULL
exception	NULL
to	NULL
this	NULL
rule	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
our	NULL
model	NULL
liver	NULL
,	NULL
infiltration	NULL
is	NULL
observed	NULL
as	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4406	NULL
REGULATION	NULL
OF	NULL
AP-1	NULL
AND	NULL
NF-	NULL
«	NULL
B	NULL
DURING	NULL
CD8	NULL
T	NULL
CELL	NULL
TOLERANCE	NULL
early	NULL
as	NULL
2	NULL
days	NULL
after	NULL
adoptive	NULL
transfer	NULL
,	NULL
wheras	NULL
no	NULL
activated	NULL
T	NULL
cells	NULL
are	NULL
yet	NULL
detected	NULL
in	NULL
the	NULL
spleen	NULL
or	NULL
lymph	NULL
nodes	NULL
of	NULL
Alb-K	NULL
``	NULL
mice	NULL
.	NULL

Furthermore	NULL
,	NULL
activated	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
appear	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
Alb-K°	NULL
mice	NULL
by	NULL
day	NULL
6	NULL
after	NULL
transfer	NULL
,	NULL
when	NULL
liver	NULL
infiltration	NULL
has	NULL
almost	NULL
completely	NULL
cleared	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
liver-infiltrating	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
found	NULL
in	NULL
the	NULL
spleen	NULL
do	NULL
not	NULL
express	NULL
€D69	NULL
,	NULL
a	NULL
marker	NULL
that	NULL
is	NULL
only	NULL
transiently	NULL
expressed	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
naive	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
gain	NULL
access	NULL
to	NULL
the	NULL
liver	NULL
,	NULL
are	NULL
activated	NULL
by	NULL
H-2K®-expressing	NULL
liver	NULL
cells	NULL
,	NULL
and	NULL
then	NULL
recirculate	NULL
to	NULL
the	NULL
spleen	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
T	NULL
cell	NULL
deletion	NULL
in	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
is	NULL
still	NULL
unknown	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
T	NULL
cell	NULL
death	NULL
directly	NULL
results	NULL
from	NULL
TCR	NULL
stimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD28-dependent	NULL
costimulatory	NULL
sig-nals	NULL
.	NULL

Lack	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
antiapoptotic	NULL
molecule	NULL
Bel-x	NULL
;	NULL
;	NULL
is	NULL
thought	NULL
,	NULL
in	NULL
this	NULL
case	NULL
,	NULL
to	NULL
cause	NULL
deletion	NULL
of	NULL
the	NULL
responding	NULL
T	NULL
cells	NULL
(	NULL
39	NULL
)	NULL
.	NULL

However	NULL
,	NULL
both	NULL
Bcl-2	NULL
and	NULL
Bel-x	NULL
,	NULL
,	NULL
are	NULL
normally	NULL
expressed	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
.	NULL

An	NULL
alternative	NULL
explanation	NULL
comes	NULL
from	NULL
the	NULL
recent	NULL
observation	NULL
that	NULL
the	NULL
long-term	NULL
maintenance	NULL
of	NULL
naive	NULL
or	NULL
memory	NULL
T	NULL
cells	NULL
depends	NULL
on	NULL
survival	NULL
signals	NULL
induced	NULL
by	NULL
TCR	NULL
engagement	NULL
(	NULL
35-37	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
hepatocyte-stimulated	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
are	NULL
unre-sponsive	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
proliferate	NULL
,	NULL
produce	NULL
cytokines	NULL
,	NULL
nor	NULL
transactivate	NULL
AP-1	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
upon	NULL
in	NULL
vitro	NULL
restimulation	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
tolerized	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
present	NULL
a	NULL
generalized	NULL
defect	NULL
on	NULL
the	NULL
TCR	NULL
signaling	NULL
pathway	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
CD8	NULL
*Des*	NULL
T	NULL
cells	NULL
in	NULL
Des-	NULL
>	NULL
Alb-K	NULL
``	NULL
mice	NULL
may	NULL
therefore	NULL
result	NULL
from	NULL
a	NULL
lack	NULL
of	NULL
survival	NULL
signals	NULL
due	NULL
to	NULL
a	NULL
desensitization	NULL
of	NULL
their	NULL
TCR	NULL
.	NULL

Further	NULL
studies	NULL
of	NULL
the	NULL
exact	NULL
downstream	NULL
events	NULL
induced	NULL
by	NULL
TCR	NULL
engagement	NULL
that	NULL
regulate	NULL
T	NULL
cell	NULL
homeostasis	NULL
are	NULL
clearly	NULL
required	NULL
to	NULL
resolve	NULL
that	NULL
issue	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
transcriptional	NULL
program	NULL
expressed	NULL
by	NULL
three	NULL
different	NULL
T	NULL
cell	NULL
populations	NULL
:	NULL
1	NULL
)	NULL
unstimulated	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
Des-	NULL
>	NULL
B1OBR	NULL
)	NULL
that	NULL
have	NULL
a	NULL
life	NULL
span	NULL
of	NULL
>	NULL
50	NULL
days	NULL
,	NULL
2	NULL
)	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
primed	NULL
in	NULL
vivo	NULL
and	NULL
would	NULL
develop	NULL
under	NULL
those	NULL
conditions	NULL
into	NULL
effectors	NULL
and	NULL
memory	NULL
cells	NULL
,	NULL
and	NULL
3	NULL
)	NULL
tolerant	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
unresponsive	NULL
and	NULL
further	NULL
deleted	NULL
.	NULL

We	NULL
found	NULL
that	NULL
prone-to-die	NULL
tolerant	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
diverge	NULL
from	NULL
long-lived	NULL
naive	NULL
and	NULL
primed	NULL
T	NULL
cells	NULL
mainly	NULL
at	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
pathway	NULL
.	NULL

Indeed	NULL
,	NULL
hepatocyte-stimulated	NULL
T	NULL
cells	NULL
show	NULL
no	NULL
detectable	NULL
AP-1	NULL
and	NULL
only	NULL
a	NULL
weak	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

This	NULL
contrasts	NULL
with	NULL
primed	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
demonstrate	NULL
high	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transactivation	NULL
,	NULL
or	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
have	NULL
detectable	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

As	NULL
naive	NULL
CD8	NULL
``	NULL
Des	NULL
T	NULL
cells	NULL
,	NULL
tolerant	NULL
cells	NULL
show	NULL
no	NULL
detectable	NULL
AP-1	NULL
complexes	NULL
and	NULL
nuclear	NULL
localization	NULL
of	NULL
JunD	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Fos	NULL
family	NULL
members	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Priming	NULL
induces	NULL
an	NULL
increase	NULL
in	NULL
nuclear	NULL
JunD	NULL
and	NULL
all	NULL
Fos	NULL
family	NULL
members	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Biochemical	NULL
studies	NULL
further	NULL
revealed	NULL
an	NULL
intriguing	NULL
difference	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
expressed	NULL
by	NULL
tolerant	NULL
CD8	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
naive	NULL
or	NULL
primed	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
present	NULL
in	NULL
naive	NULL
and	NULL
primed	NULL
T	NULL
cells	NULL
are	NULL
mainly	NULL
composed	NULL
of	NULL
p65/p50	NULL
(	NULL
N1	NULL
complex	NULL
)	NULL
and	NULL
p50/p50	NULL
(	NULL
NZ	NULL
complex	NULL
)	NULL
dimers	NULL
;	NULL
priming	NULL
only	NULL
increases	NULL
the	NULL
relative	NULL
representation	NULL
of	NULL
these	NULL
complexes	NULL
and	NULL
may	NULL
induce	NULL
low	NULL
levels	NULL
of	NULL
c-Rel-containing	NULL
complexes	NULL
.	NULL

Likewise	NULL
,	NULL
at	NULL
day	NULL
5	NULL
or	NULL
10	NULL
after	NULL
in	NULL
vivo	NULL
priming	NULL
,	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
express	NULL
the	NULL
N1	NULL
and	NULL
NZ	NULL
complexes	NULL
only	NULL
at	NULL
levels	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
NF-KB	NULL
complexes	NULL
present	NULL
in	NULL
naive	NULL
and	NULL
primed	NULL
T	NULL
cells	NULL
contain	NULL
substantial	NULL
levels	NULL
of	NULL
p50	NULL
,	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
member	NULL
is	NULL
almost	NULL
undetectable	NULL
in	NULL
the	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
that	NULL
contain	NULL
p65	NULL
and	NULL
c-Rel	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
stoichiometry	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
can	NULL
not	NULL
be	NULL
clearly	NULL
established	NULL
by	NULL
supershift	NULL
experiments	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
NF-KB	NULL
complexes	NULL
detected	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
*	NULL
Des	NULL
*	NULL
may	NULL
correspond	NULL
to	NULL
homo-	NULL
or	NULL
heterodimers	NULL
of	NULL
p65	NULL
with	NULL
c-Rel	NULL
.	NULL

How	NULL
the	NULL
change	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
is	NULL
regulated	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
still	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
;	NULL
however	NULL
,	NULL
it	NULL
may	NULL
result	NULL
from	NULL
defective	NULL
TCR	NULL
signaling	NULL
or	NULL
signaling	NULL
through	NULL
other	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

Despite	NULL
the	NULL
differences	NULL
in	NULL
Ag	NULL
stimulation	NULL
,	NULL
the	NULL
response	NULL
of	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
to	NULL
H-2K	NULL
``	NULL
®-expressing	NULL
hepatocytes	NULL
and	NULL
the	NULL
in	NULL
vivo	NULL
responses	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
to	NULL
superantigens	NULL
have	NULL
similar	NULL
fea-tures	NULL
:	NULL
both	NULL
stimuli	NULL
induce	NULL
proliferation	NULL
of	NULL
the	NULL
responding	NULL
cells	NULL
and	NULL
subsequent	NULL
unresponsiveness	NULL
.	NULL

However	NULL
,	NULL
these	NULL
responses	NULL
diverge	NULL
in	NULL
that	NULL
tolerant	NULL
CD8	NULL
*Des	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
further	NULL
deleted	NULL
,	NULL
whereas	NULL
su-perantigen-stimulated	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
anergic	NULL
and	NULL
long-lived	NULL
.	NULL

In	NULL
vivo	NULL
anergized	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
showed	NULL
no	NULL
AP-1	NULL
transactivation	NULL
and	NULL
show	NULL
a	NULL
failure	NULL
of	NULL
NF-KB	NULL
activation	NULL
linked	NULL
to	NULL
reduced	NULL
nuclear	NULL
localization	NULL
of	NULL
RelA	NULL
and	NULL
c-Rel	NULL
(	NULL
26	NULL
)	NULL
.	NULL

When	NULL
comparing	NULL
these	NULL
two	NULL
different	NULL
studies	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
difference	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
'	NULL
regulation	NULL
may	NULL
determine	NULL
the	NULL
fate	NULL
of	NULL
the	NULL
responding	NULL
T	NULL
cell	NULL
's	NULL
deletion	NULL
or	NULL
survival	NULL
.	NULL

However	NULL
,	NULL
this	NULL
is	NULL
at	NULL
odds	NULL
with	NULL
recent	NULL
studies	NULL
that	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
essential	NULL
regulator	NULL
of	NULL
T	NULL
cell	NULL
survival	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

This	NULL
was	NULL
shown	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
in	NULL
T	NULL
cells	NULL
a	NULL
frams-dominant	NULL
IxBa	NULL
that	NULL
completely	NULL
blocks	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
p65/p50	NULL
complexes	NULL
,	NULL
whereas	NULL
the	NULL
regulation	NULL
of	NULL
p50	NULL
homodimers	NULL
remained	NULL
normal	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
to	NULL
reconcile	NULL
these	NULL
observations	NULL
is	NULL
that	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
have	NULL
different	NULL
roles	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
homeostasis	NULL
.	NULL

In	NULL
correlation	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
affinity	NULL
for	NULL
«	NULL
B	NULL
sites	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
depends	NULL
on	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

(	NULL
52	NULL
)	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
targeted	NULL
disruption	NULL
of	NULL
individual	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
suggested	NULL
that	NULL
the	NULL
different	NULL
proteins	NULL
have	NULL
distinct	NULL
biological	NULL
functions	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
53-56	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
,	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
p65-containing	NULL
complexes	NULL
(	NULL
N3	NULL
complexes	NULL
)	NULL
are	NULL
further	NULL
regulated	NULL
by	NULL
post-trancriptional	NULL
modifica-tion	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
their	NULL
altered	NULL
migration	NULL
in	NULL
EMSA	NULL
.	NULL

These	NULL
modifications	NULL
may	NULL
alter	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
these	NULL
complexes	NULL
,	NULL
a	NULL
possibility	NULL
that	NULL
still	NULL
needs	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

Further	NULL
characterization	NULL
of	NULL
the	NULL
NF-kB	NULL
complexes	NULL
detected	NULL
in	NULL
the	NULL
tolerant	NULL
CD8	NULL
``	NULL
Des	NULL
*	NULL
T	NULL
cell	NULL
population	NULL
may	NULL
help	NULL
to	NULL
determine	NULL
to	NULL
what	NULL
extent	NULL
«	NULL
B-dependent	NULL
gene	NULL
expression	NULL
participates	NULL
in	NULL
T	NULL
cell	NULL
survival	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
R.	NULL
A.	NULL
Flavell	NULL
and	NULL
S.	NULL
Ghosh	NULL
for	NULL
providing	NULL
us	NULL
the	NULL
AP-1-	NULL
and	NULL
NF-	NULL
«	NULL
B-Luc-transgenic	NULL
mice	NULL
,	NULL
B.	NULL
Arnold	NULL
and	NULL
G.	NULL
Himmerling	NULL
for	NULL
the	NULL
Désiré	NULL
and	NULL
Alb-K	NULL
``	NULL
mice	NULL
,	NULL
and	NULL
M.	NULL
Pophillat	NULL
for	NULL
animal	NULL
care	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
C.	NULL
Boyer	NULL
,	NULL
M.	NULL
Buferne	NULL
,	NULL
A.	NULL
Guimezanes	NULL
,	NULL
B.	NULL
Malissen	NULL
,	NULL
and	NULL
L.	NULL
Leserman	NULL
for	NULL
critical	NULL
experimental	NULL
advice	NULL
,	NULL
helpful	NULL
discussion	NULL
,	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Morahan	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Allison	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
A.	NULL
P.	NULL
Miller	NULL
.	NULL

1989	NULL
.	NULL

Tolerance	NULL
of	NULL
class	NULL
I	NULL
his-tocompatability	NULL
antigens	NULL
expressed	NULL
extrathymically	NULL
.	NULL

Nature	NULL
339:622	NULL
.	NULL

2	NULL
.	NULL

Kurts	NULL
,	NULL
C.	NULL
,	NULL
W.	NULL
R.	NULL
Heath	NULL
,	NULL
H.	NULL
Kosaka	NULL
,	NULL
J.	NULL
F.	NULL
Miller	NULL
,	NULL
and	NULL
F.	NULL
R.	NULL
Carbone	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
peripheral	NULL
deletion	NULL
of	NULL
autoreactive	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
cross-presentation	NULL
of	NULL
self-antigens	NULL
involves	NULL
signaling	NULL
through	NULL
CD95	NULL
(	NULL
Fas	NULL
,	NULL
Apo-1	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188	NULL
:	NULL
415	NULL
.	NULL

3	NULL
.	NULL

Bertolino	NULL
,	NULL
P.	NULL
,	NULL
W.	NULL
R.	NULL
Heath	NULL
,	NULL
C.	NULL
L.	NULL
Hardy	NULL
,	NULL
G.	NULL
Morahan	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
A.	NULL
P.	NULL
Miller	NULL
.	NULL

1995	NULL
.	NULL

Peripheral	NULL
deletion	NULL
of	NULL
autoreactive	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
H-2K	NULL
``	NULL
in	NULL
the	NULL
liver	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:1932	NULL
.	NULL

4	NULL
.	NULL

Fields	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1992	NULL
.	NULL

Organ	NULL
injury	NULL
associated	NULL
with	NULL
extrathymic	NULL
induction	NULL
of	NULL
immune	NULL
tolerance	NULL
in	NULL
doubly	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:5730	NULL
.	NULL

5	NULL
.	NULL

Schonrich	NULL
,	NULL
G.	NULL
,	NULL
U.	NULL
Kalinke	NULL
,	NULL
F.	NULL
Momburg	NULL
,	NULL
M.	NULL
Malissen	NULL
,	NULL
A.-M.	NULL
Schimtt-Verhulst	NULL
,	NULL
B.	NULL
Malissen	NULL
,	NULL
G.	NULL
J.	NULL
Hammerling	NULL
,	NULL
and	NULL
B.	NULL
Arnold	NULL
.	NULL

1991	NULL
.	NULL

Down-regulation	NULL
of	NULL
T	NULL
cell	NULL
receptors	NULL
on	NULL
self-reactive	NULL
T	NULL
cells	NULL
as	NULL
a	NULL
novel	NULL
mechanism	NULL
for	NULL
extrathymic	NULL
tolerance	NULL
induction	NULL
.	NULL

Cell	NULL
65:293	NULL
.	NULL

6	NULL
.	NULL

G.	NULL
,	NULL
F.	NULL
Momburg	NULL
,	NULL
M.	NULL
Malissen	NULL
,	NULL
A.	NULL
M.	NULL
Schmitt-Verhulst	NULL
,	NULL
B.	NULL
Malissen	NULL
,	NULL
G.	NULL
J.	NULL
Hammerling	NULL
,	NULL
and	NULL
B.	NULL
Amold	NULL
.	NULL

1992	NULL
.	NULL

Distinct	NULL
mechanisms	NULL
of	NULL
extrathymic	NULL
T	NULL
cell	NULL
tolerance	NULL
due	NULL
to	NULL
differential	NULL
expression	NULL
of	NULL
self	NULL
antigen	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

4:581	NULL
.	NULL

7	NULL
.	NULL

Scott	NULL
,	NULL
B.	NULL
,	NULL
R.	NULL
Liblau	NULL
,	NULL
S.	NULL
Degermann	NULL
,	NULL
L.	NULL
A.	NULL
Marconi	NULL
,	NULL
L.	NULL
Ogata	NULL
,	NULL
A.	NULL
J.	NULL
Caton	NULL
,	NULL
H.	NULL
0	NULL
.	NULL

McDevitt	NULL
,	NULL
and	NULL
D.	NULL
Lo	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
role	NULL
for	NULL
non-MHC	NULL
genetic	NULL
polymorphism	NULL
in	NULL
susceptibility	NULL
to	NULL
spontancous	NULL
autoimmunity	NULL
.	NULL

Immunity	NULL
1:73	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Boussiotis	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
G.	NULL
J.	NULL
Freeman	NULL
,	NULL
J.	NULL
G.	NULL
Gribben	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Nadler	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
B7-1/B7-2	NULL
:	NULL
CD28/CLTA-4	NULL
pathways	NULL
in	NULL
the	NULL
prevention	NULL
of	NULL
anergy	NULL
,	NULL
induction	NULL
of	NULL
productive	NULL
immunity	NULL
and	NULL
down-regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

153:5.	NULL
.	NULL

Guerder	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1995	NULL
.	NULL

Costimulation	NULL
in	NULL
tolerance	NULL
and	NULL
autoimmu-	NULL
nity	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13:135	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Loh	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

AP-1	NULL
transcriptional	NULL
activity	NULL
requires	NULL
both	NULL
T-cell	NULL
receptor-mediated	NULL
and	NULL
co-stimulatory	NULL
signals	NULL
in	NULL
primary	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4370	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kalunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

Wisdom	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
S.	NULL
Johnson	NULL
,	NULL
and	NULL
C.	NULL
Moore	NULL
.	NULL

1999.	NULL
c-Jun	NULL
regulates	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
apoptosis	NULL
by	NULL
distinct	NULL
mechanisms	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

18:188	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

May	NULL
,	NULL
and	NULL
E.	NULL
B.	NULL
Kopp	NULL
.	NULL

1998	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
Rel	NULL
proteins	NULL
:	NULL
evolu-tionarily	NULL
conserved	NULL
mediators	NULL
of	NULL
immune	NULL
responses	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16	NULL
:	NULL
225	NULL
.	NULL

Kontgen	NULL
,	NULL
F.	NULL
,	NULL
R.	NULL
J.	NULL
Grumont	NULL
,	NULL
A.	NULL
Strasser	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
R.	NULL
Li	NULL
,	NULL
D.	NULL
Tarlinton	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1995	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
c-Rel	NULL
proto-oncogene	NULL
exhibit	NULL
defects	NULL
in	NULL
lymphocyte	NULL
proliferation	NULL
,	NULL
humoral	NULL
immunity	NULL
,	NULL
and	NULL
interleukin-2	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1965	NULL
.	NULL

Doi	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
T.	NULL
Takahashi	NULL
,	NULL
O.	NULL
Taguchi	NULL
,	NULL
T.	NULL
Azuma	NULL
,	NULL
and	NULL
Y.	NULL
Obata	NULL
.	NULL

1997	NULL
.	NULL

NF-kB	NULL
RelA-deficient	NULL
lymphocytes	NULL
:	NULL
normal	NULL
development	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
impaired	NULL
production	NULL
of	NULL
IgA	NULL
and	NULL
IgG1	NULL
and	NULL
reduced	NULL
proliferative	NULL
responses	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:953	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
degeneration	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-B	NULL
.	NULL

Nature	NULL
376:167	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
essential	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
preventing	NULL
TNF-a-induced	NULL
cell	NULL
death	NULL
.	NULL

Science	NULL
274:782	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Martin	NULL
,	NULL
T.	NULL
Kafri	NULL
,	NULL
D.	NULL
Green	NULL
,	NULL
and	NULL
I.	NULL
Verma	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
TNF-a-induced	NULL
apoptosis	NULL
by	NULL
NF-KB	NULL
.	NULL

Science	NULL
274:787	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Mayo	NULL
,	NULL
and	NULL
A.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

TNF-	NULL
and	NULL
cancer	NULL
therapy-induced	NULL
apoptosis	NULL
:	NULL
potentiation	NULL
by	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
274:784	NULL
.	NULL

Liu	NULL
,	NULL
Z.-G.	NULL
,	NULL
H.	NULL
Hsu	NULL
,	NULL
D.	NULL
Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
1	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-KB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
87:565	NULL
.	NULL

Boothby	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Mora	NULL
,	NULL
D.	NULL
Schere	NULL
,	NULL
J.	NULL
Brockman	NULL
,	NULL
and	NULL
D.	NULL
Ballard	NULL
.	NULL

1997	NULL
.	NULL

Perturbation	NULL
of	NULL
the	NULL
T	NULL
lymphocyte	NULL
lineage	NULL
In	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
B	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1897	NULL
.	NULL

Ferreira	NULL
,	NULL
V.	NULL
,	NULL
N.	NULL
Sidenius	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
P.	NULL
Hubert	NULL
,	NULL
L.	NULL
Chatenoud	NULL
,	NULL
F.	NULL
Blasi	NULL
,	NULL
and	NULL
M.	NULL
Korner	NULL
.	NULL

1999	NULL
.	NULL

In	NULL
vivo	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T-lineage	NULL
cells	NULL
leads	NULL
to	NULL
a	NULL
dramatic	NULL
decrease	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
cytokine	NULL
production	NULL
and	NULL
to	NULL
increased	NULL
cell	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
,	NULL
but	NULL
not	NULL
to	NULL
abnormal	NULL
thymopoiesis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:6442	NULL
.	NULL

Hettmann	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
DiDonato	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1999	NULL
.	NULL

An	NULL
essential	NULL
role	NULL
for	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
in	NULL
promoting	NULL
double	NULL
positive	NULL
thymocyte	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

189:145	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
B.	NULL
Beverly	NULL
,	NULL
A-C.	NULL
Tran	NULL
,	NULL
K.	NULL
Brorson	NULL
,	NULL
R.	NULL
H.	NULL
Schwartz	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
by	NULL
AP-1	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
of	NULL
T-cell	NULL
clonal	NULL
anergy	NULL
.	NULL

Science	NULL
257:1134	NULL
.	NULL

Sundstedt	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Sigvardsson	NULL
,	NULL
T.	NULL
Leanderson	NULL
,	NULL
G.	NULL
Hedlung	NULL
,	NULL
T.	NULL
Kalland	NULL
,	NULL
and	NULL
M.	NULL
Dohisten	NULL
.	NULL

1996	NULL
.	NULL

In	NULL
vivo	NULL
anergized	NULL
CD4*	NULL
T	NULL
cells	NULL
express	NULL
perturbed	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:979	NULL
.	NULL

Sundstedt	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
Dohlsten	NULL
.	NULL

1998	NULL
.	NULL

In	NULL
vivo	NULL
anergized	NULL
CD4*	NULL
T	NULL
cells	NULL
have	NULL
defective	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
the	NULL
activating	NULL
protein-1	NULL
transcription	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:5930	NULL
.	NULL

Voll	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
E.	NULL
Jimi	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
D.	NULL
F.	NULL
Barber	NULL
,	NULL
M.	NULL
Rincon	NULL
,	NULL
A.	NULL
C.	NULL
Hayday	NULL
,	NULL
R.	NULL
A.	NULL
Flavell	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

2000	NULL
.	NULL

NF-KB	NULL
activation	NULL
by	NULL
the	NULL
pre-T	NULL
cell	NULL
receptor	NULL
serves	NULL
as	NULL
a	NULL
selective	NULL
survival	NULL
signal	NULL
in	NULL
T	NULL
lymphocyte	NULL
development	NULL
.	NULL

Immunity	NULL
13:677	NULL
.	NULL

Yeoman	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
Mellor	NULL
.	NULL

1992	NULL
.	NULL

Tolerance	NULL
and	NULL
MHC	NULL
restriction	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
MHC	NULL
class	NULL
I	NULL
gene	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

4:59	NULL
.	NULL

Lyons	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Parish	NULL
.	NULL

1994	NULL
.	NULL

Determination	NULL
of	NULL
lymphocyte	NULL
division	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
171:131	NULL
.	NULL

Guerder	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
E.	NULL
Picarella	NULL
,	NULL
P.	NULL
S.	NULL
Linsley	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

Costimulator	NULL
B7-1	NULL
confers	NULL
antigen-presenting-cell	NULL
function	NULL
to	NULL
parenchymal	NULL
tissue	NULL
and	NULL
in	NULL
conjunction	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
leads	NULL
to	NULL
autoimmunity	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5138	NULL
.	NULL

Reiner	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
S.	NULL
Zheng	NULL
,	NULL
D.	NULL
B.	NULL
Corry	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Locksley	NULL
.	NULL

1993	NULL
.	NULL

Constructing	NULL
polycompetitor	NULL
cDNAs	NULL
for	NULL
quantitative	NULL
PCR	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
165:37	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

4407	NULL
Phillips	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
IB	NULL
in	NULL
WEHI	NULL
231	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:4390	NULL
.	NULL

Kearney	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
Pape	NULL
,	NULL
D.	NULL
Loh	NULL
,	NULL
and	NULL
M.	NULL
Jenkins	NULL
.	NULL

1994	NULL
.	NULL

Visualization	NULL
of	NULL
peptide-specific	NULL
cell	NULL
immunity	NULL
and	NULL
peripheral	NULL
tolerance	NULL
induction	NULL
in	NULL
vivo	NULL
.	NULL

Immunify	NULL
1:327	NULL
.	NULL

Goldrath	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Bevan	NULL
.	NULL

1999	NULL
.	NULL

Low-affinity	NULL
ligands	NULL
for	NULL
the	NULL
TCR	NULL
drive	NULL
proliferation	NULL
of	NULL
mature	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
lymphopenic	NULL
hosts	NULL
.	NULL

Immunity	NULL
11:183	NULL
.	NULL

Ernst	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
S.	NULL
Lee	NULL
,	NULL
J.	NULL
M.	NULL
Chang	NULL
,	NULL
J.	NULL
Sprent	NULL
,	NULL
and	NULL
C.	NULL
D.	NULL
Surh	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
peptide	NULL
ligands	NULL
mediating	NULL
positive	NULL
selection	NULL
in	NULL
the	NULL
thymus	NULL
control	NULL
T	NULL
cell	NULL
survival	NULL
and	NULL
homeostatic	NULL
proliferation	NULL
in	NULL
the	NULL
periphery	NULL
.	NULL

Immunity	NULL
11:173	NULL
.	NULL

Viret	NULL
,	NULL
C.	NULL
,	NULL
F.	NULL
S.	NULL
Wong	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Janeway	NULL
,	NULL
Jr.	NULL
1999	NULL
.	NULL

Designing	NULL
and	NULL
maintaining	NULL
the	NULL
mature	NULL
TCR	NULL
repertoire	NULL
:	NULL
the	NULL
continuum	NULL
of	NULL
self-peptide	NULL
:	NULL
self-MHC	NULL
complex	NULL
recognition	NULL
.	NULL

Immunity	NULL
10:559	NULL
.	NULL

Sprent	NULL
,	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Immunological	NULL
memory	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:371	NULL
.	NULL

Dahl	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
C.	NULL
Klein	NULL
,	NULL
P.	NULL
G.	NULL
Andres	NULL
,	NULL
C.	NULL
A.	NULL
London	NULL
,	NULL
M.	NULL
P.	NULL
Lodge	NULL
,	NULL
R.	NULL
C.	NULL
Mulligan	NULL
,	NULL
and	NULL
A.	NULL
K.	NULL
Abbas	NULL
.	NULL

2000	NULL
.	NULL

Expression	NULL
of	NULL
bel-X	NULL
;	NULL
,	NULL
restores	NULL
cell	NULL
survival	NULL
,	NULL
but	NULL
not	NULL
proliferation	NULL
off	NULL
effector	NULL
differentiation	NULL
,	NULL
in	NULL
CD28-deficient	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

191:2031	NULL
.	NULL

Petschner	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Zimmerman	NULL
,	NULL
A.	NULL
Strasser	NULL
,	NULL
D.	NULL
Grillot	NULL
,	NULL
G.	NULL
Nunez	NULL
,	NULL
and	NULL
H.	NULL
Pircher	NULL
.	NULL

1998	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
;	NULL
,	NULL
or	NULL
Bcl-2	NULL
prevents	NULL
peptide	NULL
antigen-in-duced	NULL
T	NULL
cell	NULL
deletion	NULL
but	NULL
does	NULL
not	NULL
influence	NULL
T	NULL
cell	NULL
homeostasis	NULL
after	NULL
a	NULL
viral	NULL
infection	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:560	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
C.-W.	NULL
Chow	NULL
,	NULL
R.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

Reprogramming	NULL
the	NULL
signalling	NULL
requirement	NULL
for	NULL
AP-1	NULL
(	NULL
activator	NULL
protein-1	NULL
)	NULL
activation	NULL
during	NULL
differentiation	NULL
of	NULL
precursor	NULL
CD4*	NULL
T-cells	NULL
into	NULL
effector	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Genes	NULL
Funct	NULL
.	NULL

1:51	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
M.	NULL
Rincon	NULL
,	NULL
K.	NULL
D.	NULL
McCoy	NULL
,	NULL
and	NULL
G.	NULL
Le	NULL
Gros	NULL
.	NULL

1999	NULL
.	NULL

CTLA4	NULL
ligation	NULL
attenuates	NULL
AP-1	NULL
,	NULL
NFAT	NULL
and	NULL
NF-KB	NULL
activity	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

29:838	NULL
.	NULL

Millet	NULL
,	NULL
L.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
R.	NULL
S.	NULL
Sherwin	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
R.	NULL
E.	NULL
Voll	NULL
,	NULL
R.	NULL
A.	NULL
Flavell	NULL
,	NULL
A.	NULL
Vignery	NULL
,	NULL
and	NULL
M.	NULL
Rincon	NULL
.	NULL

2000	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-KB	NULL
activity	NULL
and	NULL
enhancement	NULL
of	NULL
apoptosis	NULL
by	NULL
the	NULL
neuropeptide	NULL
calcitonin	NULL
gene-related	NULL
peptide	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275:15114.	NULL
.	NULL

Auphan	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
R.	NULL
A.	NULL
Flavell	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Schmitt-Verhulst	NULL
.	NULL

1999	NULL
.	NULL

Differ	NULL
ential	NULL
requirements	NULL
for	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
trans-activation	NULL
in	NULL
response	NULL
to	NULL
minimal	NULL
TCR	NULL
engagement	NULL
by	NULL
a	NULL
partial	NULL
agonist	NULL
in	NULL
naive	NULL
CD8	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163	NULL
;	NULL
5219	NULL
.	NULL

Zhong	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
E.	NULL
Voll	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1998	NULL
.	NULL

Phosphorylation	NULL
of	NULL
NF-kB	NULL
p65	NULL
by	NULL
PKA	NULL
stimulates	NULL
transcriptional	NULL
activity	NULL
by	NULL
promoting	NULL
a	NULL
novel	NULL
bivalent	NULL
interaction	NULL
with	NULL
the	NULL
coactivator	NULL
CBP/p300	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
1:661	NULL
.	NULL

Levkau	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Scatena	NULL
,	NULL
C.	NULL
M.	NULL
Giachelli	NULL
,	NULL
R.	NULL
Ross	NULL
,	NULL
and	NULL
E.	NULL
W.	NULL
Raines	NULL
.	NULL

1999	NULL
.	NULL

Apoptosis	NULL
overrides	NULL
survival	NULL
signals	NULL
through	NULL
a	NULL
caspase-mediated	NULL
dominant-neg-ative	NULL
NF-KB	NULL
loop	NULL
.	NULL

Nat	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

1:227	NULL
.	NULL

Ravi	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Bedi	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Fuchs	NULL
.	NULL

1998	NULL
.	NULL

CD95	NULL
(	NULL
Fas	NULL
)	NULL
-induced	NULL
caspase-mediated	NULL
proteolysis	NULL
of	NULL
NF-B	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

58:882	NULL
.	NULL

Bertolino	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
C.	NULL
Trescol-Biemont	NULL
,	NULL
and	NULL
C.	NULL
Rabourdin-Combe	NULL
.	NULL

1998	NULL
.	NULL

Hepatocytes	NULL
induce	NULL
functional	NULL
activation	NULL
of	NULL
naive	NULL
CD8	NULL
*	NULL
T	NULL
lymphocytes	NULL
but	NULL
fail	NULL
to	NULL
promote	NULL
survival	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:221	NULL
.	NULL

Bertolino	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
C.	NULL
Trescol-Biemont	NULL
,	NULL
J.	NULL
Thomas	NULL
,	NULL
B.	NULL
F.	NULL
de	NULL
St.	NULL
Groth	NULL
,	NULL
M.	NULL
Pihlgren	NULL
,	NULL
J.	NULL
Marvel	NULL
,	NULL
and	NULL
C.	NULL
Rabourdin-Combe	NULL
.	NULL

1999	NULL
.	NULL

Death	NULL
by	NULL
neglect	NULL
as	NULL
a	NULL
deletional	NULL
mechanism	NULL
of	NULL
peripheral	NULL
tolerance	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

11:1225	NULL
.	NULL

Tanchot	NULL
,	NULL
C.	NULL
,	NULL
F.	NULL
A.	NULL
Lemonnier	NULL
,	NULL
B.	NULL
Peramnau	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Freitas	NULL
,	NULL
and	NULL
B.	NULL
Rocha	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
requirements	NULL
for	NULL
survival	NULL
and	NULL
proliferation	NULL
of	NULL
CD8	NULL
naive	NULL
or	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
276:2057	NULL
.	NULL

Kirberg	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Berns	NULL
,	NULL
and	NULL
H.	NULL
von	NULL
Bochmer	NULL
.	NULL

1997	NULL
.	NULL

Peripheral	NULL
T	NULL
cell	NULL
survival	NULL
requires	NULL
continual	NULL
ligation	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
to	NULL
major	NULL
histocompatibility	NULL
com-plex-encoded	NULL
molecules	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1269	NULL
.	NULL

Sicbenlist	NULL
,	NULL
U.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
K.	NULL
Brown	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
,	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:405	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
S.	NULL
K.	NULL
Durham	NULL
,	NULL
D.	NULL
S.	NULL
Barton	NULL
,	NULL
C.	NULL
A.	NULL
Rizzo	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
S.	NULL
A.	NULL
Lira	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1995	NULL
.	NULL

Multiorgan	NULL
inflammation	NULL
and	NULL
hematopoietic	NULL
abnormalities	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
RelB	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
.	NULL

Cell	NULL
80:331	NULL
.	NULL

Carrasco	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Cheng	NULL
,	NULL
A.	NULL
Lewin	NULL
,	NULL
G.	NULL
Warr	NULL
,	NULL
H.	NULL
Yang	NULL
,	NULL
C.	NULL
Rizzo	NULL
,	NULL
F.	NULL
Rosas	NULL
,	NULL
C.	NULL
Snapper	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1998	NULL
.	NULL

Multiple	NULL
hemopoietic	NULL
defects	NULL
and	NULL
lymphoid	NULL
hyperplasia	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
c-Rel	NULL
protein	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:973	NULL
.	NULL

Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
E.	NULL
I.	NULL
Tuomanen	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-KB	NULL
leads	NULL
to	NULL
multifocal	NULL
defects	NULL
in	NULL
immune	NULL
responses	NULL
.	NULL

Cell	NULL
80:321	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
P.	NULL
Zelazowski	NULL
,	NULL
F.	NULL
R.	NULL
Rosas	NULL
,	NULL
M.	NULL
R.	NULL
Kehry	NULL
,	NULL
M.	NULL
Tian	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Sha	NULL
.	NULL

1996	NULL
.	NULL

B	NULL
cells	NULL
from	NULL
pSO/NE-B	NULL
knockout	NULL
mice	NULL
have	NULL
selective	NULL
defects	NULL
in	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
germ-line	NULL
CH	NULL
transcription	NULL
,	NULL
and	NULL
Ig	NULL
class	NULL
switching	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:183	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

